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Chapter 1: Summary 
 
The first part of the research project of the Co-Advisorship Ph.D Thesis was aimed 
to select the best Bifidobacterium longum strains suitable to set the basis of our 
study. We were looking for strains with the abilities to colonize the intestinal 
mucosa and with good adhesion capacities, so that we can test these strains to 
investigate their ability to induce apoptosis in “damaged” intestinal cells. Adhesion 
and apoptosis are the two process that we want to study to better understand the 
role of an adhesion protein that we have previously identified and  that have top 
scores homologies with the recent serpin encoding gene identified in B. longum by 
Nestlè researchers. Bifidobacterium longum is a probiotic, known for its beneficial 
effects to the human gut and even for its immunomodulatory and antitumor 
activities. Recently, many studies have stressed out the intimate relation between 
probiotic bacteria and the GIT mucosa and their influence on human cellular 
homeostasis. We focused on the apoptotic deletion of cancer cells induced by B. 
longum. This has been valued in vitro, performing the incubation of three B.longum 
strains with enterocyte-like Caco-2 cells, to evidence DNA fragmentation, a 
cornerstone of apoptosis. The three strains tested were defined for their adhesion 
properties using adhesion and autoaggregation assays. These features are 
considered necessary to select a probiotic strain. The three strains named B12, B18 
and B2990 resulted respectively: “strong adherent”, “adherent” and “non adherent”. 
Then, bacteria were incubated with Caco-2 cells to investigate apoptotic deletion. 
Cocultures of Caco-2 cells with B. longum resulted positive in DNA fragmentation 
test, only when adherent strains were used (B12 and B18). These results indicate 
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that the interaction with adherent B. longum can induce apoptotic deletion of Caco-
2 cells, suggesting a role in cellular homeostasis of the gastrointestinal tract and in 
restoring the ecology of damaged colon tissues. These results were used to keep on 
researching and the strains tested were used as recipient of recombinant techniques 
aimed to originate new B.longum strains with enhanced capacity of apoptotic 
induction in “damaged” intestinal cells. To achieve this new goal it was decided to 
clone the serpin encoding gene of  B. longum, so that we can understand its role in 
adhesion and apoptosis induction. Bifidobacterium longum has immunostimulant 
activity that in vitro can lead to apoptotic response of Caco-2 cell line. It secretes a 
hypothetical eukaryotic type serpin protein, which could be involved in this kind of 
deletion of damaged cells. We had previously characterised a protein that has 
homologies with the hypothetical serpin of B. longum (DD087853). In order to 
create Bifidobacterium serpin transformants, a B. longum cosmid library was 
screened with a PCR protocol using specific primers for serpin gene. After 
fragment extraction, the insert named S1 was sub-cloned into pRM2, an 
Escherichia coli - Bifidobacterium shuttle vector, to construct pRM3. Several 
protocols for B. longum transformation were performed and the best efficiency was 
obtained using MRS medium and raffinose. Finally bacterial cell supernatants were 
tested in a dot-blot assay to detect antigens presence against anti-antitrypsin 
polyclonal antibody. The best signal was produced by one starin that has been 
renamed B. longum BLKS 7. Our research study was aimed to generate 
transformants able to over express serpin encoding gene, so that we can have the 
tools for a further study on bacterial apoptotic induction of Caco-2 cell line. 
After that we have originated new trasformants the next step to do was to test 
transformants abilities when exposed to an intestinal cell model. In fact, this part of 
the project was achieved in the Department of Biochemistry of the Medical Faculty 
of the University of Maribor,  guest of the abroad supervisor of the Co-Advisorship 
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Doctoral Thesis: Prof. Avrelija Cencic.  In this study we examined the probiotic 
ability of some bacterial strains using intestinal cells from a 6 years old pig. The 
use of intestinal mammalian cells is essential to study this symbiosis and a 
functional cell model mimics a polarised epithelium in which enterocytes are 
separated by tight junctions.  
In this list of strains we have included the Bifidobacterium longum BKS7 
transformant strain that we have previously originated; in order to compare its 
abilities. B. longum B12 wild type and B. longum BKS7 transformant and eight 
Lactobacillus strains of different sources were co-cultured with porcine small 
intestine epithelial cells (PSI C1) and porcine blood monocytes (PoM2) in 
Transwell filter inserts. The strains, including Lb. gasseri, Lb. fermentum, Lb. 
reuterii, Lb. plantarum and unidentified Lactobacillus from kenyan maasai milk 
and tanzanian coffee, were assayed for activation of cell lines, measuring nitric 
oxide by Griess reaction, H202 by tetramethylbenzidine reaction and O2- by 
cytochrome C reduction. Cytotoxic effect by crystal violet staining and induction 
on metabolic activity by MTT cell proliferation assay were tested too. 
Transepithelial electrical resistance (TER) of polarised PSI C1 was measured 
during 48 hours co-culture. TER, used to observe epithelium permeability, decrease 
during pathogenesis and tissue becomes permeable to ion passive flow lowering 
epithelial barrier function. Probiotics can prevent or restore increased permeability. 
Lastly, dot-blot was achieved against Interleukin-6 of treated cells supernatants.  
The metabolic activity of PoM2 and PSI C1 increased slightly after co-culture not 
affecting mitochondrial functions. No strain was cytotoxic over PSI C1 and PoM2 
and no cell activation was observed, as measured by the release of NO2, H202 and 
O2- by PoM2 and PSI C1. During co-culture TER of polarised PSI C1 was two-fold 
higher comparing with constant TER (~3000 Ω) of untreated cells. TER raise 
generated by bacteria maintains a low permeability of the epithelium. During 
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treatment Interleukin-6 was detected in cell supernatants at several time points, 
confirming immunostimulant activity. All results were obtained using 
Lactobacillus paracasei Shirota e Carnobacterium divergens as controls. 
 
 
 
Chapter 2: Biology of Bifidobacterium spp. 
 
 
2. 1: Taxonomy 
 
Classification and taxonomy of bifidobacteria have been a source of controversy 
since their discovery more than a hundred years ago. In 1899, Tissier isolated 
Gram-positive, anaerobic bacteria with a hitherto unknown Y-shaped morphology 
from the faeces of breast-fed infants, which he termed Bacillus bifidus communis 
(lat. bifidus: cleft, divided; Tissier, 1900). Shortly after the introduction of the 
Lactobacillaceae in 1917, the Tissier strains were integrated in this new family by 
Holland (1920) and renamed to Lactobacillus bifidus. In 1924, Orla-Jensen 
suggested the new genus Bifidobacterium for the representatives of the species 
based on morphological, cultural, and biochemical investigations. However, the 
former nomenclature prevailed, and only fifity years later the bifidobacteria 
officially obtained their deserved status as a separate genus by the publication of 
the VIIIth edition of Bergey’s Manual of Determinative Bacteriology (Buchanan 
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and Gibbons, 1974). This reclassification was the consequence of sugar 
fermentation studies (Dehnert, 1957; Reuter, 1963), of the discovery of the 
bifidobacterial hexose catabolism (see below) as well as of analyses of the genomic 
G+C content, in which bifidobacteria strongly differ from the lactic acid bacteria. 
Today, the genus Bifidobacterium is included in the newly established class 
Actinobacteria, the Gram-positive bacteria with a high G+C content in their 
genome (Schleifer and Ludwig, 1995; Stackebrandt et al.,1997). Currently 
approximately 30 species are differentiated, but as the flood of new publications 
referring to this topic shows (Cai et al., 2000; Dong et al., 2000; Hoyles et al., 
2002; Jiang and Dong, 2002; Sakata et al., 2002; Ventura and Zink, 2002; Zhu et 
al., 2003), the Bifidobacterium taxonomy will stay in a constant state of flux at 
least in the near future. Bifidobacteria can shortly be characterised as Gram-
positive, non sporeforming, non motile, catalase negative, fermentative rods 
exhibiting pleomorphism, the cells being short or long, irregular, often curved, bifid 
or multiple-branched. The G+C content of their DNA varies from 55 to 67% 
(Biavati and Mattarelli, 2001). They are generally regarded as strictly anaerobic, 
yet some species possess a considerable oxygen tolerance (Meile et al., 1997). 
They grow optimally between 37 and 41°C at pH values of 6.5 to 7, with the 
exception of the newly described B. thermacidophilum, which is able to grow at up 
to 49.5°C and at pH 4 (Dong et al., 2000). Along with Bacteroides, Eubacterium, 
Clostridium, Lactobacillus, Fusobacterium, Peptococcus, Peptostreptococcus, 
Enterococcus, Staphylococcus, Veillonella, and Enterobacteriaceae species, 
bifidobacteria belong to the predominant bacterial groups within the intestinal 
microflora of humans (Savage, 1977; Mitsuoka, 1992), representing up to 15% of 
the cultivable bacteria of this ecosystem in adults and being the main pioneer 
colonisers in newborns (Marteau et al., 2001; Tuohy et al., 2001). Bifidobacteria 
are also widespread in the gastrointestinal tract of animals such as calves, lambs, 
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pigs, chickens, rabbits, rats, and even honeybees. Besides, they can be isolated 
from the human vagina, from the human oral cavity, and from sewage. In general, 
Bifidobacterium species are specific for either humans or animals, whereby the 
occurrence of the same species in suckling calves and breast-fed infants is the 
exception (Biavati and Mattarelli, 2001). 
 
2. 2: Morphology 
 
The group of bacteria that belong to the genus Bifidobacterium presents a rod-
shape morphology, Gram positive, non motile and non sporeforming. This group of 
rod shaped bacteria have an irregular shape that lenght on average between 2 and 5 
µm and presents swelling ends with club or slice form and with one ore more 
branches, but even more regular and cocci shape are not so rare. This type of 
polymorphism is generally species-specific, so that even the kind of morphology 
can be used for identification of bacteria. However, even in one single species it is 
possible to have different cells with different shapes; this is particularly due to 
growth conditions. Stress conditions as low pH, extreme temperatures or nitrogen 
starvation can trigger morphological alterations of bacterial cells that swell. When 
Bifidobacterium bifidum var. pensylvanicus is cultivated in a media without N-
acethylglucosamine, the main component of glycane, assumes a club shape. When 
bifidobacteria are cultivated in a poor medium cells present the typical “Y” shape, 
but as soon as some aminoacids like, alanine, glutamic acid, serine ad aspartic acid, 
are added, cells tend to assume a rod shape. Probably, these aminoacids are 
implicated in peptidoglycan formation so that this pleomorphysm is due more to an 
altered synthesis than to degenerative process (Husain et al., 1972).  Even Ca++ ions 
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content can influence bacterial morphology; a low content causes “Y” shapes, 
while an high content causes rod shapes (Kojima et al., 1970). 
 
2. 3: Membrane and Cell Wall 
 
Since1970 cell wall composition and peptidoglycan structure of Bifidobacteria 
have been studied and it has been sentenced that, like all Gram+ bacteria, cell wall 
is set up by a single homogenous layer of peptidoglycan , assembled from N-
acethylmuramic acid (NAM) and N-acethylglutamic acid (NAG) with glycosidic β-
1,4 bonds. A peptidic chain formed by four aminoacids (L-alanine, D-glutamate, L-
lysine or L-ornithine and D-alanine) is bond to NAM carboxyl termini, instead this 
region represents the conservative region of Bifidobacterium genus. The variable 
region is set up by peptidic chains that link the conservative tetrapeptides between 
two peptidoglycan chain. The sequence of this aminoacidic bonds differs at 
interspecific level. Peptidoglycan is not the sole component of cell wall of 
Bifidobacteria, instead there are high contents of polysaccharides as, glucose and 
galactose linked to ramnose and high contents of teichoic acids (TA) and 
lipoteichoic acids (LTA). Teichoic acids are acid polysaccharides and represent the 
10-15% of cell wall weight. These polymers can contains up to thirty glycerol-
phosphate or ribitol-phosphate molecules linked to phosphate bonds. Sugars as, 
glucose or galactose, or aminoacids as, D-alanine, can be linked to hydrogen oxide 
ions of the alcohol and figure as antigenic determinants at serotype level. They are 
bound to 6-OH- group in NAM structure of peptidoglycan. Lipoteichoic acids are 
teichoic acids generally set up by glycerol-phosphate chains, including a fatty acid 
that is used to bound to membrane lipids. LTAs get through cell wall and extend 
outside (Veerkamp et al. 1983). LTAs and TAs have structural functions, 
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contributing to the strength and the flexibility of cell wall and are immunogenic. 
Moreover can contribute to cations assumption because repeated phosphate groups 
make molecules strongly acid and negatively charged, thus facilitating cations 
bonds (Ca++, K+, Mg++) and assumption. Further studies demonstrate that these 
lipoteichoic acids, single or associated with proteins, are  responsible for the 
surface hydrophobicity of Bifidobacteria (Op den Camp et al. 1985). Cytoplasmatic 
membrane of Bifidobacterium bifidum has been exhaustively studied. Looks like a 
9 nm depth structure set up by a double lipidic layer in which is inserted a single 
proteic layer. Membrane lipids are exclusively phospholipidsas, phosphathydil-
glycerol, diphosphathydil-glycerol and polyglycerol-phospholipids (Exterkate et 
al., 1971). Instead, myristic acid, palmitic acid, stearic acid and oleic acid are the 
most representative fatty acids of these membrane phospholipids (Ballongue, 
1993). Membrane proteins are non-glycosilated and can be integrated or peripheric. 
Inside cytoplasma, plasmatic membrane generates several invaginations, called 
mesosomes, that differs at intraspecific level based on growth conditions 
(Greenwalt and Whiteside, 1975).         
 
2. 4: Metabolism 
 
2. 4. 1: Fermentation of simple charbohydrates  
In the context of the use of bifidobacteria as probiotics and their role as target 
organisms for prebiotic substances the biochemical and genetic background of the 
bifidobacterial carbohydrate catabolism is of increasing interest. The fermentation 
ability of simple and complex carbohydrates varies widely within the genus 
(Biavati and Mattarelli, 2001) and was therefore a preferred method for species 
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identification (Mitsuoka, 1969) before less time-consuming molecular methods 
were introduced. Poly- and oligosaccharides are degraded by extra- and/or 
intracellular enzymes to their monomers before being further processed by the 
intermediary metabolism. The catabolism of hexoses in Bifidobacterium species 
follows a characteristic pathway known as the fructose 6-phosphate (F6P) or 
bifid(us) shunt as shown in figure 2. 1 (Scardovi, 1964; Scardovi and Trovatelli, 
1965; De Vries et al., 1967).  
 
 
Fig. 2. 1: The fructose 6-phosphate or bifidus shunt as described by Scardovi and 
Torvatelli (1965) and De Vries et al.(1967). F6PPK and X5PPK, fructose 6-
phosphate and xylulose 5-phosphate phosphoketolase, respectively. 
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The key enzyme of this pathway is fructose 6-phosphate phosphoketolase (F6PPK), 
which cleaves the hexose phosphate into erythrose 4-phosphate and acetyl 
phosphate. By the subsequent action of transaldolase and transketolase, pentose 
phosphates are formed from the tetrose phosphate and fructose 6-phosphate, which 
are then split by xylulose 5-phosphate phosphoketolase (X5PPK) into acetyl 
phosphate and glyceraldehydes 3-phosphoate, finally ending up in acetic and L(+)-
lactic acids (Figure 2. 2). The apparently exclusive occurrence of F6PPK in 
Bifidobacteriaceae led to the common use of its activity as a definitive 
identification criterion for this family (Biavati and Mattarelli, 2001). The most 
important differences between the F6P and the phosphoketolase shunts are the lack 
of carbon dioxide production by bifidobacteria (except during gluconate 
degradation) and the ratio of the two primary fermentation products. While 
heterofermentative lactic acid bacteria produce at most equal amounts of acetate 
and lactate as their fermentation end products, the theoretical ratio of 3:2 
(acetate/lactate) is the result of the F6P pathway. They explained it by the 
phosphoroclastic split of a part of the pyruvate into formic and acetic acids and the 
partial reduction of the latter to ethanol. The enzyme responsible for this reaction 
has never been purified or characterised; however, a gene coding for a putative 
pyruvate formate lyase is represented in the genome of B. longum bv. longum. 
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Fig. 2. 2: Phosphoketolase shunt of obligatory and facultative heterofermentative 
lactic acid bacteria. X5PPK, xylulose 5-phosphate phosphoketolase 
 
The energy gained from glucose fermentation through the F6P shunt is 2.5 mol of 
ATP per mol of substrate and thus exceeds the yield obtained by homolactic (2 mol 
of ATP) or heterolactic (1 to 2 mol of ATP) fermentation (Buckel, 1999). A high 
yield of ATP does not necessarily have to be favourable; it is rather a high rate of 
ATP synthesis which allows bacteria to successfully outcompete others having a 
lower metabolic activity (Unden, 1998). Pathways other than the F6P shunt have 
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never been proven to exist in bifidobacteria, and glycolytic enzymes as well as 
those of the oxidative branch of the pentose phosphate pathway are generally 
assumed to be absent (Schlegel, 1992). Glucose 6-phosphate dehydrogenase and 6-
phosphogluconate dehydrogenase (Scardovi and Trovatelli, 1969) as well as 
aldolase (Scardovi et al., 1969) were reported to occur in several strains of animal 
origin. The physiological role of these enzymes in bifidobacteria remains unclear. 
Another glycolysis enzyme, phosphofructokinase, was found to be necessary as a 
supplier of fructose 1,6-bisphosphate, which was revealed to function as an 
essential activator of lactate dehydrogenase in B. bifidum (De Vries et al., 1967). 
 
2. 4. 2: Glucosidases and complex charbohydrates 
Bifidobacteria have the capacity to metabolise even  complex carbohydrates and 
this ability cover a fundamental role for bacterial growth, thus simple sugurs are 
rare to be found in the tract of colon, because this kind of sugars are firstly 
metabolised by saccharolytic species that habit the colon and are easily absorbed by 
the small intestine. For this reason the main source of degradable carbohydrates in 
the colon at disposition of bifidobacteria are complex carbohydrates. To this group 
belongs all that diet fibres as, cellulose, emicellulose, pectic substances, and all that 
mucines that protect the intestinal mucosa as, glycoproteins with fucose, esosamine 
and salicylic acids. Unfortunately, the aspect of metabolic processes that degrade 
these polymers known as fructo-oligosaccharides (FOS) is still not so clear. FOS 
are recognise as molecules with glucose and fructose residues linked by β-1,2 or  β-
1,6 bonds. These carbohydrates are not fermented by intestinal mucosa enzymes, 
but are fermented by intestinal bacterial species, particularly by bifidobacteria. 
Many studies have been reported about selection of bifidobacterial strains that can 
better use these polymers. Once these bacteria are inoculed in the host with their 
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colonization and persistence produce precursors that can be used by those bacteria 
incapable to ferment complex sugars (Scardovi V., 1969). In particular, some 
studies have revealed that porcine gastric mucine is preferably degraded by 
bifidobacterial species as, B. bifidum, B. infantis and B. longum Scardovi V., 1986). 
Bifidobacteria can ferment several different sugars, some like lactose, galactose or 
saccharose are fermented by the most of the species, but others like sorbitol or 
mannitol are metabolised just by few species. In some cases, this could be due to 
the fact that most species do not posses the specific sugar phosphotrasferase system 
(PTS). Once sugars get trough cell membrane, oligosaccharides and disaccharides 
are hydrolysed by specific glycosidases, while complex polysaccharides as 
amylase, amylopectin, xylan or arabic gum are degraded  by specific extracellular 
enzymatic systems. 
 
2. 5: Physiology 
 
2. 5. 1: Temperatures and Ph 
The origin of the different species of bifidobacteria reflect the different optimal 
temperature needed for their growth. Species of human origin prefer a range of 
temperature between 37° and 41° C and cannot stand temperatures higher than 45° 
C. In the most of the species of animal origin growth is possible even at more than 
45° C, while it has never been demonstrate that these bacteria can live at 
temperature lower than 25° C. When bacteria are stored at 4° C, cultures are viable 
up to 1 month; when are harvested at -80° C, their full viability can be prolonged 
for several years, but when are lyophilised the cultures can be recovered even after 
30 years. Bifidobacteria are acid tolerant microrganisms, but not acidophil, so they 
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grow in medium with a pH range between 5 and 7 preferring a restrict pH range 
between 6.5 and 7.  Growth inhibition is obtained at pHs lower than 5 and higher 
than 8 (Scardovi V., 1986). Sometimes pH is used as selection tool in the medium 
culture. 
 
2. 5. 2: Respiration 
Bifidobacteria are anaerobe microrganisms, but oxygen sensibility differs from 
different species and different strains. There are strains less strictly anaerobe and 
there are mutant strains facultative anaerobe. The mechanisms that are implicated 
in oxygen tolerance are not well known. Anyway, bifidobacteria are catalase 
negative microrganisms, but among the aero-tolerant species B. indicum and B. 
asteroides become catalase-positive if grown in the presence of oxygen, 
respectively with or without the addiction of hemin. It has been hypothesed that 
atmospheric oxygen can interfere by two different mechanisms: helping redox 
potential, in this case the increasing oxygen is not lethal but can stop the growth of 
some strains, or producing H2O2, inhibitor of fructose-6-phosphate 
phosphoketolase, the key enzyme for sugar metabolism in bifidobacteria. Oxygen 
tolerance can be interpreted as  an eventual capacity to degrade hydrogen peroxide 
(due to the slightly catalase activity as shown for B. indicum and B. asteroides) or 
to prevent its formation (due to the presence of NADH oxydase) (Scardovi V., 
1986).  
 
2. 5. 3: Antibiotic Resistance 
Antibiotic resistance studies applied to bifidobacteria are necessary to outline 
selective treatments against pathogen microrganisms that do not affect 
bifidobacterial cells already present inside the gastro-intestinal tract. Antibiotics 
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can be use added to culture medium to discriminate bacterial species and isolate 
bifidobacteria in a heterogenic sample (e.g. stool sample). After several researches 
it has been stated that: the most of bifidobacterial species is resistant to many 
antibiotics and in particular to nalidixic acid, gentamycin, metronidazide, 
neomycin, polymyxin b and streptomycin, but the sensibility to this antibiotics 
differs among different species. Ampicillin, bacitracin, cloramphenicol, 
clindamycin, herythromycin, cincomycin, nitrofuralon, oleandomycin, penicillin G 
and vancomycin strongly inhibits the most of bifidobacterial species. Tetracycline 
resistance vary from species to species and from strains to strains (Scardovi V., 
1986). For the isolation and identification of bifidobacterial species in dairy 
products, the use of dicloxacillin has been particularly efficient. As it has been 
described, the addition of dicloxacillin in a concentration of 2 pg/ml to the culture 
medium can discriminate all lactobacilli and streptococci from resistant 
bifidobacteria. 
 
 
 
Chapter 3: Ecology of Bifidobacterium spp. 
 
3. 1: Habitat 
The group of species that has been isolated so far comes from different sources and 
habits different niches. Human origin bifidobacteria are mainly colon resident, in 
fact it is indicative that their presence is massively reported in fecal samples of 
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healthy humans and in the newborns. Species have been isolated from the oral 
cavity (B. denticolens, B. dentium and B. inopitatum) and even from vagina (B. 
bifidum, B. breve, B. catenulatum, B. infantis and B. longum), were represent a part 
of a consortium formed by other lactic acid bacteria (e.g. Lactobacillus spp.). 
Bifidobacteria of animal origin are mainly reported from mammal source. Presence 
of these bacteria has been highlighted in fecal samples from: rat, dog, cattle, pig, 
chicken, rabbit, while three species has been isolated from bees intestine. Some 
species seem to be host-specific, for example B. magnum, B. suis and B. pullorum 
have been specifically isolated in rabbit, pig and chicken, respectively. B. dentium 
is constantly associated with dental caries. B. minimum and B. subtile have been 
isolated from sewage and these two new species are the sole reported to habits non-
living ecological niches (Table 3. 1).  
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Species Habitat 
B. adolescentis 
B. animalis 
B. angulatum 
B. asteroides 
B. bifidum 
B. boum  
B. breve, 
B. catenulatum 
B. choerinum 
B. coryneforme 
B. cuniculi 
B. dentium  
B. denticolens aka Parascardovia denticolens 
B. gallinarum 
B. globosum 
B. infantis  
B. inopitatum aka Scardovia inopinata 
B. longum 
B. lactis 
B. magnum 
B. merycicum 
B. minimum 
B. pseudocatenulatum 
B. pseudolongum 
B. pollorum 
B. ruminantium 
B. saeculare 
B. subtile 
B. suis 
Adult human; bovine, sewage. 
Rat, chicken, cattle, rabbit and sewage 
Sewage and adult human 
Bees 
Adult human, newborn, cattle and human vagina 
Bovine and weaning pig 
Newborn, cattle, human vagina, sewage 
Newborn, cattle, human vagina, sewage 
Weaning pig and sewage 
Apis mellifera 
Rabbit 
Adult human, oral caries, dental abscess, vagina  
Oral cavity 
Chicken cecum tract 
Weaning pig, cattle, rat, rabbit and sewage 
Newborn, cattle, human vagina 
Oral cavity 
Newborn, cattle, human vagina, sewage 
Newborn 
Rabbit 
Bovine 
Sewage 
Newborn, cattle and sewage 
Pig, chicken, rabbit, cattle, rat, guinea pig 
Chicken 
Bovine 
Rabbit 
Sewage 
Weaning pig 
Tab. 3. 1: Datas were obtained from Scardovi (1974), Lauer (1977) and (Watanabe 
1995).  
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3. 2: Gastro-intestinal tract 
The main habitat of bifidobacteria species is the gastro-intestinal tract of mammals. 
They represent an important part of human fecal flora both in the newborns and in 
the adults. The most of bifidobacterial species habits the colon, coexisting with a 
lot of other different strictly anaerobe microrganisms. During prenatal life the 
foetus lives in an aseptic habitat and just at the time of birth starts to get colonised 
by the mother fecal and vaginal microbiota. After weaning a natural and gradual 
change happens in the  microbiota intestine; while, bifidobacteria decrease in 
number, others anaerobes like Bacteroides, Peptostreptococcus, Eubacterium, 
Fusobacterium and clostridia notably increase.  Several studies have outlined that  
a progressive colonization of the intestinal tract is an important prerequisite to 
development immune system tolerance, about which loss could generate allergies 
and intolerancies (Figure 3. 1; Table 3. 2).   
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Fig. 3. 1: The gastrointestinal tract ecosystem showing the microbiota composition. 
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Gastrointestinal bacterial species 
 
Stomach       
(pH 2 – 2.4) 
 
Jejunum          
(pH 7.5) 
 
Ileum      
(pH 6) 
 
Colon           
(pH 5.5 – 7.5) 
 
Total concentration of bacterial species  
 
0 – 3 
 
0 – 6 
 
3 – 7 
 
10 - 12 
 
Aerobes and Facoltative Anaerobes 
Enterobacter spp. 
Streptococcus spp. 
Staphylococcus spp. 
Lactobacillus spp. 
 
 
0 – 2 
0 - 3 
0 – 2 
0 – 3 
 
 
0 – 3 
0 – 4 
0 – 3 
0 – 4 
 
 
2 – 5 
2 – 6 
2 – 5 
2 – 5 
 
 
4 – 10 
5 – 10 
4 - 7 
6 - 10 
 
Strictly Anaerobes 
Bacteroides spp. 
Bifidobacterium spp. 
Peptococcus spp. 
Clostridium spp. 
Fusobacterium spp. 
Eubacterium spp. 
Veillonella spp. 
 
 
Rare 
Rare 
Rare 
Rare 
Rare 
Rare 
Rare 
 
 
 
0 – 2 
0 – 3 
0 – 3 
Rare 
Rare 
Rare 
0 – 2 
 
 
 
3 – 6 
3 – 7 
3 – 4 
3 – 4 
Rare 
3 – 5 
3 - 4 
 
 
9 – 11 
8 – 10 
8 – 10 
6 – 10 
9 – 10 
9 - 10 
3 – 5 
 
Tab. 3. 2: Most common species in the GIT microbiota of healthy humans. 
 
Bifidobacteria skips from being the main bacterial genre in infants during weaning, 
to being the third or forth main bacterial group once the subject is adult. At the age 
of 65 the number of bifidobacterial species cells strongly decrease up for the 
increasing of lactobacilli, clostridia, streptococci and E. coli species. Moreover 
bifidobacterial species vary during host life cycle; in infants are present B infantis, 
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B. longum, B. bifidum and B. breve, while after weaning the most important species 
are B. catenulatum, B. longum and B. pseudocatenulatum (Table 3. 3). The 
intestinal microbiota maintains itself in a constant and sensitive equilibrium, thus 
stress, diet changes, pharmaceutical therapies, antibiotic treatments can degenerate 
so far this balance up to the vanish of some species. 
 
Population Main species Minor species 
Breast-fed newborns B. longum                                     
B. infantis                                    
B. breve 
B. bifidum 
 
Bottle-fed newborns B. adolescentis B.bifidum 
Infants B. infantis                                    
B. breve                                                                              
B. longum 
B. adolescentis                           
B. catenulatum                                   
Adults B. adolescentis                           
B. longum                                   
B. catenulatum                                   
B. breve 
B. bifidum 
Elders B. adolescentis                                             
B. longum 
B. catenulatum        
Tab. 3. 3: Bifidobacteria isolated from stool samples of healthy humans  
 
3. 3: Mucosa interactions 
Microrganisms can be found moving free in a solution just during a transitory stage 
of their life, instead, particularly bacteria, they are found associated in a complex 
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community, as a biofilm, which permit the adhesion to surface. Studies have 
demonstrate that is more probable that bacteria tend to adhere when are in the log 
phase of growth. Inside the community of the biofilm, a single bacterial cell have 
many advantages; for example: it is protected from host phagocytosis and from 
toxic components released by host metabolism and it is anchored to the matrix, thus 
resisting to peristaltic movements. In nature, bacterial biofilms can be found 
practically in every environment and so even in mammals gastrointestinal tract. 
Biofilm development can take days and weeks and starts from a reversible 
absorption stage, passing to a non reversible absorption stage, then to cell division 
and bacterial growth stage and to the stage of polymers production and biofilms 
establishment and concludes with the of aggregation of others bacteria to the 
growing community (Figure 3. 2). From the first moment that there is an interface 
contact can be distinguish two kinds of interactions, from microrganisms and 
microrganisms and from microrganisms and surface. These interactions can be site 
specific, as the link ligand/receptor , or even non specific, as the hydrophobic 
interactions between adhesion proteins and lipoteichoic acids or the process of co-
aggregation that results in adhesion between bacterial cells. Gastrointestinal tract is 
a very complex habitat where bacteria are exposed not only to molecules produced 
by other microrganisms, but even to that molecules produced by epithelial cells. of 
the mucosa..  
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Fig. 3. 2: Schematic representation of biofilm formation 
 
3. 3. 1: Adhesion 
Bacterial adhesion to different matrix is a fundamental strategy for bacterial growth 
and niche’s colonisation. Considering the gastrointestinal tract, there is to know 
that adhesion process of bacterial cells is a complex and multipartite phenomenon, 
which include the secretion of growth inhibitors, as bacteriocin, organic acid or 
reactive oxygen species, physiological changes and a non specific activation of the 
host immune system. The several steps required for adhesion are strongly 
influenced by several external biotic and non biotic factors. The first step consists 
in the approach of bacterial cells to the matrix to be colonised. This is possible due 
to the active or passive motility of bacteria, as the presence of pili or flagella or 
thanks to sedimentation and Brownian motion. In any case, a bacteria first to 
adhere to a  biotic matrix has to overcome an energetic barrier (Gibbs energy), of 
which intensity is due to combined action of electrostatic forces and 
 30
electrodynamic forces, as Van der Waals force. Electrostatic force is always 
attractive, because are dependent of the ionic double layer electric charge, that form 
between two negative charged surfaces. Rather, electrodynamic forces are 
attractive, once  from one or from both surfaces are secreted or are produced 
molecules that increase the matrix area. These two kind of molecules are able to 
alter the surface hydrophobicity charge; in fact, an elevated hydrophobicity rate 
results in a loss of Gibbs energy, permitting more easily to bacteria to reach the 
surface to be colonised. Once bacteria have overcome Gibbs energy  and approach 
the surface they hit it and attach to it. If the period in which the interface remain 
linked is short, we can talk of adhesion, while if the period is prolonged in time, we 
can talk of attachment. Adhesion is encouraged by smooth surfaces and concern 
just non specific, short ranged and relatively weak forces. Instead, attachment is 
promoted by non regular surfaces and concern specific and non specific forces that 
improve a strong bond between bacterial ligands and eukaryotic receptors. 
Attachment lead off out and out colonisation due to the establishment of strong 
bonds between the interface. During colonisation bacteria are growing and produce 
exopolymers that are used to extend outside forming a fibre matrix that lead to the 
formation of microcolonies and biofilms. 
 
3. 3. 2: Proteins involved in adhesion 
These molecules are of different kinds and vary from simple carbohydrates to 
complex proteins. Specificity of interaction is modulated by proteins known as 
adhesins that interact with the different components of extracellular matrix as 
fibronectin and collagen. In the class of adhesins are included adhesins and lectins. 
The firsts are highly conserved proteins, in which the mutation even of a single 
aminoacid  lead to a change in bond affinity with sugars present in receptor’s active 
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site; while lectins are proteins capable to bind sugars specifically or able to mediate 
the link between different sugars. Receptors that interact with proteins are equally 
important in adhesion mechanism and are characterised by the presence of different 
sugars or for the presence of sialic acid. The toll-related proteins, of which until to 
date about 12 have been identified, are highly conserved through evolution. The 
TLRs are expressed on both enterocyte and immune cells. They recognize specific 
microbial components through leucine rich region domains (LRRs), such as surface 
determinants, lipopolysaccharide (LPS) of Gram-negative bacteria (TLR2 and 
TLR4) and unmethylated CpG DNA sequences (TLR9). Their activation induce the 
production of T-helper 1 (Th1) cytokines through a processn dependent on NF-κB 
activation (Miettinen et al., 2000). LPS and the Lipid A fraction of LPS is 
recognized by TLR4. In humans the D299G mutation, affecting the LRR domain of 
TLR4, is associated with a blunted response to inhalated LPS. An increased 
expression of this receptor in the epithelial cells of patients with inflammatory 
bowel diseases has been related to changes in the intestinal flora (Cario and 
Podolski, 2000). In pathogenesis, bacterial adhesion has been particularly studied, 
because is one of the stages that precede infection. (Table 3. 4).  
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Adhesion factors Description  Action 
Adhesins Surface proteins Bind bacteria to a specific 
surface 
Receptors Complementary macromolecule 
binding site  
Bind eukaryotic cells to 
specific adhesins or ligands 
Lectins Surface protein  Bind to sugars 
Ligands Surface molecule Bind to a specific receptor 
Mucous Mucopolysaccharide layer          
of glycosaminoglycans  
Cover the surface of 
mammals epithelial cells 
 
Pili Chain of oligomeric                   
pilin proteins 
Bind bacteria to a specific 
surface 
Fimbriae Filamentous protein Permit bacteria to bind to a 
specific surface  
Glycocalyx Surface polysaccharides Involvement in adhesion 
 
Capsule Surface polysaccharides layer Mediation of bacterial 
attachment 
Lipoplysaccharides (LPS) Cell wall components Mediation of bacterial 
specific adhesion 
Teichoic and lipoteichoic acids  Cell wall component Involvement in specific 
adhesion 
Tab. 3. 4: Some factors involved in microrganisms-host interactions with 
descriptions and modes of action.  
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3. 4: Probiotic role 
 
3. 4. 1: Probiotic overview 
The Greek meaning of the word probiotic is "for life." One early formal definition 
was that of Parker (1974): "Organisms and substances which contribute to intestinal 
microbial balance." However, this was subsequently refined by Fuller (1989) whose 
revised definition is "A live microbial feed supplement which beneficially affects 
the host animal by improving its intestinal microbial balance." This version 
emphasizes the need for the supplement to be composed of viable microorganisms 
and is the most widely used and accepted definition. Probiotics, therefore, aim to 
produce a beneficial effect on the host by administration of viable microorganisms 
such as those found in traditional yogurts and other fermented foods, as well as 
powders, tablets, liquid suspensions and lyophilized forms in capsules. 
Monocultures as well as mixed species (up to nine) can be used in individual 
products. Primarily, these are lactic acid–excreting bacteria such as lactobacilli, 
streptococci, lactococci or bifidobacteria, although some yeasts and other fungi are 
also used. Metchnikoff (1907) first developed the concept of what we now know as 
probiotics at the beginning of this century. His hypothesis was that the complex 
microbiota of the colon was having an adverse effect on the host through what he 
termed the "autointoxication effect." As such, he believed that modification of the 
activity of the colonic microflora could occur through the ingestion of soured milks. 
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The theory was developed after he observed that Bulgarian peasants consumed 
large quantities of such milks and exhibited longevity. Metchnikoff isolated the 
bacteria responsible and used them in human feeding trials. After Metchnikoff’s 
death, Rettger and colleagues became interested in the mechanism of the probiotic 
effects and researched the use of intestine-derived species (Rettger et al. 1935). The 
field then took a number of scientific progressions to reach today’s situation in 
which live microbial feed additions are ubiquitous. 
 
3. 4. 2: Immuno-stimulation 
When the antigen gets into the body by an oral route, the systemic immune 
stimulation is produced by the cytokines released by lymphoid cells associated with 
the mucosa, which interact with the antigen. This response may be measured 
through in vitro assays by determining the cellular activity (e.g., the phagocytic 
activity) or the products released during the cellular interactions; examples are 
cytokines, using special cellular lines, such as the mono Mac 6 human macrophage 
cell line; human epithelioid carcinoma, cell transfected with cDNA for IL4 and 
IL5; and Caco-2 human colon carcinoma cell line. Then, the systemic immune 
response may be determined by measuring the nonspecific immune response 
through phagocytic activity of the peritoneal macrophages, which were stimulated 
by interleukins, and the specific immune response may be evaluated by measuring 
the activation grade of T-lymphocytes by assays of delayed-type hypersensitivity or 
by antibody level increased from T-lymphocytes and B-lymphocytes activation 
through cytokines. However, great activation of the immune system in a healthy 
host cannot be conveniently obtained, because the immune system is always in 
equilibrium with other systems (e.g., the nervous and endocrine systems); a general 
activation of the immune system by constant antigen stimulation could produce 
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negative effects on the host, including autoimmunity. A circumstance that would 
require immune system stimulation is primarily immunosuppression from 
antitumor therapies, but never when this immunosuppression is caused by a therapy 
for autoimmune illness. Lactic acid bacteria might benefit the host in some 
situations, such as to prevent enteric infections or to act as immunomodulatory 
agents in other processes. The therapeutic use of lactic acid bacteria must consider 
the effects of these bacteria on the intestinal microenvironment, especially the 
microflora, which are responsible for oral tolerance (Perdigon et al., 1995). 
 
3. 4. 3: Colon cancer 
Cancer of the colon is one of the leading causes of cancer morbidity and mortality 
among men and women in the Western countries, including the United States 
(Parker et al. 1997). Epidemiologic studies suggest that increased consumption of 
fruits and vegetables and high total dietary fiber reduce the risk of development of 
colon cancer (Howe et al. 1992). Human metabolic and laboratory animal model 
studies indicate that beneficial effects of dietary fiber in relation to colon cancer 
development depend on the composition and physical properties of the fiber (Reddy 
et al. 1992; 1995). Among the types of dietary fiber, inulin and oligofructose, 
which occur in common food stuffs such as chicory, leeks, garlic, onion, artichoke 
and asparagus at high levels, are ß (2 1)D fructans. They are fermented by colonic 
microflora and behave as soluble fibers (Gibson and Roberfroid 1995). It is of great 
interest that they selectively stimulate the growth of bifidobacteria at the expense of 
bacteriodes, clostridia or coliforms, which are maintained at low levels (Gibson and 
Roberfroid 1995, Gibson et al. 1995 ). Bacterial fermentation of these prebiotics 
produces short-chain fatty acids (SCFA) in the colon, including a small amount of 
butyric acid (Campbell et al. 1997 , Gibson and Roberfroid 1995), which has been 
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shown to increase apoptosis in the colon (Hague et al. 1993). Of special interest are 
the beneficial effects of certain lactic acid–producing enterobacterial food 
supplements, probiotics, in the prevention of cancer (Hitchins and McDonough 
1989). The lactic cultures, which are primarily used for fermentation of milk and 
other dairy products, have also been shown to possess antimutagenic and 
anticarcinogenic properties (Lidbeck et al. 1992). Colorectal cancer is now widely 
accepted to be the result of an accumulation of mutations in specific genes 
controlling cell division, apoptosis and DNA repair. There is also a wealth of 
evidence that dietary factors, including dietary fat and fibre, influence the 
development of colorectal cancer. However, until recently, there has been little 
understanding of how these dietary factors and genetic factors interact. It is 
generally believed that this interaction is mediated in part by events occurring in 
the lumen of the large bowel. IQ, a heteroxyclic aromatic amine produced from 
food pyrolysis, was first isolated from broiled fish. Subsequently, it was isolated 
from a variety of broiled or cooked fish and meat (Kasai et al. 1980). Because IQ 
induces colon tumors in male and female rats and mammary tumors in female rats, 
and bacterial cultures that ferment milk possess anticarcinogenic properties, the 
possibility exists that these bacterial cultures may prevent IQ-induced 
carcinogenesis. Accordingly the inhibitory effect of lyophilized cultures of B. 
longum on IQ-induced carcinogenesis was investigated in male and female F344 
rats (Reddy and Rivenson 1993 ). The results indicated that lyophilized cultures of 
B. longum significantly inhibited the IQ-induced incidence (percentage of animals 
with tumors) of colon tumors (100% inhibition) and multiplicity of colon tumors 
(tumors per animal) in male rats. In diet intervention studies, Gibson et al. (1995) 
demonstrated that dietary administration of oligofructose or inulin significantly 
increased fecal bifidobacteria, whereas bacteriodes, clostridia and fusobacteria 
and/or gram-positive cocci were decreased on total fecal bacterial count. These 
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bifidobacteria, colonizing at the expense of enteropathogens, may bind the ultimate 
carcinogen by physically removing it via feces. The colonizing cells of 
bifidobacteria also produce lactic acid, thereby lowering the intestinal pH to create 
a bacteriocidal environment for putative enteropathogens such as E. coli and 
Clostridium perfringens, thus developing a favorable microenvironment. This 
favorable microenvironment may also involve the modulation of bacterial enzymes 
such as ß-glucuronidase that can convert procarcinogens to proximate carcinogens 
(Kulkarni and Reddy 1994). Polyamines play an essential role in cell proliferation 
and differentiation and participate in macromolecular synthesis. Ornithine 
decarboxylase (ODC) is the first and rate-limiting enzyme of this crucial polyamine 
biosynthetic pathway. Elevated levels of ODC activity have been reported in 
neoplastic human colons vs. normal-appearing colonic mucosa (Porter et al. 1987, 
Singh et al. 1992). Studies demonstrate that the colon tumor inhibitory property of 
lyophilized cultures of B. longum was associated with the inhibition of colonic 
mucosal cell proliferation and with suppression of ODC activity in the colonic 
mucosa and tumors compared with that in control diet. Aberrant crypt foci (ACF), 
which are recognized as early preneoplastic lesions in the colon, have consistently 
been observed in experimentally induced colon carcinogenesis in laboratory 
animals and in the colonic mucosa of patients with colon cancer (McLellan et al. 
1991). ACF also express mutations in the APC gene and ras oncogene that are 
involved in colon cancer development (Vivona et al. 1993). Aberrant crypts are 
putative precursor lesions from which adenomas and carcinomas may develop in 
the colon. Several inhibitors of ACF formation have been shown to reduce the 
incidence of colon tumors in laboratory animals (Wargovich et al. 1996), 
suggesting that ACF induction can be used to evaluate novel agents for their 
potential chemopreventive properties against colon cancer. Studies were also 
conducted to evaluate the inhibitory properties of lyophilized cultures of B. longum 
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against induced colonic ACF development (Kulkarni and Reddy 1994). The results 
indicate that dietary administration of lyophilized cultures of B. longum 
significantly inhibited the total ACF formation and crypt multiplicity. The study 
results provide evidence for potential colon tumor-inhibitory properties of B. 
longum.  Ras activation represents one of the earliest and most frequently occurring 
genetic alterations associated with human cancers, especially the cancer of the 
colon (Barbacid 1990). Elevated levels of ras-p21 have been correlated with 
increased cell proliferation, histologic grade, nuclear anaplasia and degree of 
undifferentiation (Kotsinas et al. 1993). Dietary B. longum cultures significantly 
suppressed the expression of total and mutated ras p-21 in the colonic mucosa and 
tumors compared with the control diet. After all these informations this chapter 
conclude stating that dietary administration of prebiotics such as oligofructose, 
inulin and lyophilized cultures of B. longum inhibits the formation of preneoplastic 
lesions in the colon. In addition, dietary administration of lyophilized cultures of B. 
longum suppressed colon and mammary carcinogenesis in the laboratory animal 
models. Inhibition of colon carcinogenesis by lyophilized cultures of B. longum is 
associated with the modulation of colonic cell proliferation and colonic mucosal 
and tumor ODC and ras p-21. Further studies are required to investigate the 
efficacy of prebiotics in combination with probiotics on the inhibition of colon 
tumors. Although pre- and probiotics comprise a diverse group with different 
modes of action, their ability to inhibit colon carcinogenesis may be important to 
the development of potential nutritional and related food supplements against colon 
cancer. 
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3. 5: Apoptosis 
 
3. 5. 1: Cell Death Overview 
That cell death is a completely normal process in living organisms was already 
discovered by scientists more than 100 years ago. The German scientist Carl Vogt 
was first to describe the principle of apoptosis in 1842. In 1885, anatomist Walther 
Flemming delivered a more precise description of the process of programmed cell 
death. However, it was not until 1965 that the topic was resurrected. Apoptosis ( 
apo - from,  ptosis – falling) was distinguished from traumatic cell death by Wyllie, 
Kerr   and Cormack in a publication of 1972, originally using  for the first time the 
term " apoptosis " to describe the phenomenon of natural cell death. In Greek, 
apoptosis means "dropping off" of petals or leaves from plants or trees. Cormack 
reintroduced the term for medical use as it had a medical meaning for the Greeks 
over two thousand years before. Hippocrates used the term to mean "the falling off 
of the bones". Galen extended its meaning to "the dropping of the scabs". Cormack 
was no doubt aware of this usage when he suggested the name.Programmed cell 
death is an integral part of both plant and animal tissue development. Development 
of an organ or tissue is often preceded by the extensive division and differentiation 
of a particular cell, the resultant mass is then "pruned" into the correct form by 
apoptosis. Unlike cellular death caused by injury, apoptosis results in cell shrinkage 
and fragmentation. This allows the cells to be efficiently phagocytosed and their 
components reused without releasing potentially harmful intracellular substances 
(such as hydrolytic enzymes, for example) into the surrounding tissue. Apoptosis 
can occur when a cell is damaged beyond repair, infected with a virus, or 
undergoing stress conditions such as starvation. DNA damage from ionizing 
radiation or toxic chemicals can also induce apoptosis via the actions of the tumor-
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suppressing gene p53. The "decision" for apoptosis can come from the cell itself, 
from the surrounding tissue, or from a cell that is part of the immune system. In 
these cases apoptosis functions to remove the damaged cell, preventing it from 
sapping further nutrients from the organism, or to prevent the spread of viral 
infection. Apoptosis also plays a role in preventing cancer; if a cell is unable to 
undergo apoptosis, due to mutation or biochemical inhibition, it can continue 
dividing and develop into a tumor. For example, infection by papillomavirus causes 
a viral gene to interfere with the cell's p53 protein, an important member of the 
apoptotic pathway. This interference in the apoptotic capability of the cell plays a 
critical role in the development of cervical cancer. Although many pathways and 
signals lead to apoptosis, there is only one mechanism that actually causes the 
death of the cell in this process; after the appropriate stimulus has been received by 
the cell and the necessary controls exerted, a cell will undergo the organized 
degradation of cellular organelles by activated proteolytic caspases. A cell 
undergoing apoptosis shows a characteristic morphology that can be observed with 
a microscope. First the cell undergoes shrinkage and rounding due to the 
breakdown of the proteinaceous cytoskeleton by caspases. Then the cytoplasm 
appears dense, and the organelles appear tightly packed. Subsequently chromatin 
undergoes condensation into compact patches against the nuclear envelope in a 
process known as pyknosis, a hallmark of apoptosis (Susin et al., 2000; Kihlmark 
et al., 2001). In the next stage the nuclear envelope becomes discontinuous and the 
DNA inside it is fragmented in a process referred to as karyorrhexis. The nucleus 
breaks into several discrete chromatin bodies or nucleosomal units due to the 
degradation of DNA (Figure 3. 3) (Nagata S., 2000).  
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Fig. 3. 3: Oligonucleosomal DNA fragmentation assessed after exposure of control 
DNA to Apoptosis-inducing factor (AIF) and to Caspase-activated DNAse (CAD). 
1) AIF alone . 2) CAD alone. 3) DNA after sequential exposure to AIF. 4) DNA 
after sequential exposure to CAD. (Susin et al., 2000). 
 
Then the cell membrane shows irregular buds known as blebs and finally the cell 
breaks apart into several vesicles called apoptotic bodies, which are then 
phagocytosed. Apoptosis progresses quickly and its products are quickly removed, 
making it difficult to detect or visualize. During karyorrhexis, endonuclease 
activation leaves short DNA fragments, regularly spaced in size. These give a 
characteristic "laddered" appearance on agar gel after electrophoresis. Tests for 
DNA laddering differentiate apoptosis from ischemic or toxic cell death (Iwata et 
al., 1994).  
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3. 5. 2: Apoptotic signals 
The process of apoptosis is controlled by a diverse range of cell signals, which may 
originate either extracellularly (extrinsic inducers) or intracellularly (intrinsic 
inducers). Extracellular signals may include hormones, growth factors, nitric oxide 
(Brüne B., 2003) or cytokines, and therefore must either cross the plasma 
membrane or transduce to effect a response. These signals may positively or 
negatively induce apoptosis; in this context the binding and subsequent initiation of 
apoptosis by a molecule is termed positive, whereas the active repression of 
apoptosis by a molecule is termed negative. Intracellular apoptotic signaling is a 
response initiated by a cell in response to stress, and may ultimately result in cell 
suicide. The binding of nuclear receptors by glucocorticoids, heat, radiation, 
nutrient deprivation, viral infection, and hypoxia are all factors that can lead to the 
release of intracellular apoptotic signals by a damaged cell. A number of cellular 
components, such as poly ADP ribose polymerase, may also help regulate 
apoptosis (Chiarugi and Moscowitz, 2002). Before the actual process of cell death 
is carried out by enzymes, apoptotic signals must be connected to the actual death 
pathway by way of regulatory proteins. This step allows apoptotic signals to either 
culminate in cell death, or be aborted should the cell no longer need to die. Several 
proteins are involved, however two main methods of achieving regulation have 
been identified; targeting mitochondria functionality, or directly transducing the 
signal via adapter proteins to the apoptotic mechanisms. The whole preparation 
process requires energy and functioning cell machinery. Even the mitochondria are 
exploited by some apoptotic pathways. Apoptotic proteins that target mitochondria 
affect them in different ways; they may cause mitochondrial swelling through the 
formation of membrane pores, or they may increase the permeability of the 
mitochondrial membrane and cause apoptotic effectors to leak out (Figure 3. 4). 
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There is also a growing body of evidence that indicates that nitric oxide (NO) is 
able to induce apoptosis by helping to dissipate the membrane potential of 
mitochondria and therefore make it more permeable (Brüne B., 2003).  
 
Fig. 3. 4: Signal induction and transduction in programmed cell death (Hengartner, 
2000). 
 
3. 5. 3: Apoptotic deletion 
Apoptosis is an important regulatory process in the protection against the 
development of cancer. Apoptosis provides an innate cellular defense against 
oncogenesis by processes that include removal of cells with genomic instability that 
have developed during oncogenesis and by deletion of cells suffering DNA insult 
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from genotoxic agents such as carcinogens (Thomson C. B., 1995; Potten and 
Grant, 1998) . Upregulation or facilitation of apoptosis during initiation events 
might increase the elimination of mutated cells that might otherwise Among the 
major genera of colonic bacteria, bifidobacteria and lactobacilli are thought to have 
beneficial effects on the human host (Orrhage and Nord, 2000). These probiotic 
bacteria were shown previously to exert some cancer protective effects in vitro and 
in vivo (Singh et al., 1997; Wollowski et al., 2001). The precise mechanisms by 
which certain probiotic bacteria exert their antitumorigenic influence are uncertain, 
but might involve modifying gut pH and increasing the net production rate of 
SCFA (mainly acetate, propionate, and butyrate) (Sakata et al., 1999), antagonizing 
pathogens through production of antimicrobial and antibacterial compounds (such 
as bacteriocins, cytokines and butyrate), stimulating immunomodulatory cells 
(Rolfe R. D., 2000), or competing with pathogens for available nutrients, receptors, 
and growth factors (Fuller and Gibson, 1997). Prebiotics are nondigestible dietary 
components that pass through the digestive tract to the colon. Thus, prebiotics are a 
potential substrate for fermentation by the microbiota and are capable of 
stimulating proliferation and/or activity of endogenous desirable bacteria (Gibson 
and Roberfroid, 1995). Prebiotics shown to stimulate the acute apoptotic  response 
to a genotoxic carcinogen (AARGC) in the rat colon. The AARGC might regulate 
mutational load in the colon and eliminate  DNAdamaged cells that might 
otherwise progress to malignancy, thereby exerting a protective effect at the early 
stages in the onset of cancer. Oligosaccharides also suppress azoxymethane 
(AOM)-induced preneoplastic aberrant crypt foci (ACF) and colon carcinogenesis 
in the rat colon (Rowland et al., 1998; Femia et al., 2002) as does wheat bran 
(McIntosh et al., 1996; Reddy et al., 2000). Prebiotics may exert their cancer 
protective effects via modulation of fermentative events, possibly by increasing 
SCFA production or by altering gut microbiota toward a more beneficial 
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composition. It was suggested that a combination of a probiotic and a prebiotic, 
termed synbiotics, might be more active than either a probiotic or prebiotic alone 
(Roberfroid M. B., 1998). This idea was supported by Rowland et al. (Rowland et 
al., 19982) who showed that administration of the prebiotic inulin with the 
probiotic Bifidobacterium longum to rats resulted in additive effects, with a more 
potent inhibition of AOM-induced ACF than administration of either inulin or B. 
longum separately. These findings raise the possibility that probiotics, prebiotics,or 
synbiotic combinations thereof might be protective against colorectal cancer by 
regulating the consequences of carcinogen-induced damage to colonic epithelial 
cells. Thus, we aimed to determine whether supplementation with either the 
probiotic bacteria Lactobacillus acidophilus and B. lactis alone or in combination 
with a moderate amount of RS could influence the acute apoptotic response to a 
genotoxic carcinogen (AARGC) and fermentative events in the colon rats. In 
conclusion, the synbiotic combination of RS and B. lactis significantly facilitated 
the apoptotic response to a genotoxic carcinogen in the distal colon of rats. It 
appears likely that ingested RS acts as a metabolic substrate, thus creating the right 
conditions for B. lactis to exert its proapoptotic action. Because the synbiotic 
combination of these agents facilitates the apoptotic response to DNA damage by a 
cancer initiator in the colon of rats, it warrants further study for its capacity to 
protect against colorectal cancer. 
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Chapter 4: Genomic of Bifidobacterium longum. 
 
 
4. 1: B. longum genome 
 
4. 1. 1: Genome overview.  
The whole sequence of the genome of Bifidobacterium longum NCC2705 has a 
2,256,646-bp, 60% G+C chromosomal replicon containing 4 nearly identical rrn 
operons, 57 tRNAs, 16 intact insertion sequence (IS) elements, as well as possible 
prophage and integrated plasmid remnants (Figure 4. 1). Eight of the IS elements 
constitute new members of five known families, including one rare IS607-type. The 
genome harbored 14 integrase_recombinase genes, 9 of which were organized in 3 
unusual and nearly identical structures and are included in a phage integrase family. 
More than 1,730 probable coding regions comprising 86% of the genome have 
been analysed. A specific or general function  was assigned to 1,225 (71%) of 
them; 1,346 (78%) were attributed  to a COG family. No functional description 
could be assigned to 505 genes (9%). Of these, 389 (22%) had no similarity to any 
predicted protein in public databases indicating either that they were either specific 
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to B. longum or that they remain to be identified in other genomes (Schell et al., 
2002). When the best BLASTP hits for each predicted protein were parsed by 
organism, it has been found that 34% of the ORFs had best hits from Streptomyces 
coelicolor, 9.3% from M.tuberculosis, and 3.8% from Corynebacterium 
glutamicum. This finding confirms assignment of B. longum to the 
Actimomycetales group. Surprisingly, a disparate number of best hits were found in 
genomes of phylogenetically distant genera that include GIT inhabitants. For 
example, 5.3% of the best hits were from Clostridia, 4.0% from Streptococcus, and 
1.9% from Escherichia coli, whereas 0.7% were found in any other single 
prokaryotic genome. 
 
 
Fig. 4. 1: Linear map of the B. longum chromosome. (A) Scale in Mb. (B) Coding 
regions by strand. Upper and lower lines represent plus and minus strand ORFs, 
respectively. Arrows indicate transition points in cumulative GC skew from 
ORILOC. (C) G+C content with scale (window 1,000). Roman numerals mark 
regions where G+C is 2.5 SD units below average. (D) Intact (two IS3-type, five 
IS21-type, three IS30-type, five IS256-type, and one IS607-type) as well as partial 
IS elements are represented by vertical lines; boxes mark possible prophage 
remnant (PR) and integrated plasmid (PL). Filled circles represent rRNA operons. 
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Positions of the 3 nearly identical copies of the potentially new type of mobile 
genetic element in B. longum are indicated by triangles and an expanded view of 
one shown. The three different integrases (Int) are represented by arrows; the 
interrupted IS3-type element containing them is hatched. Black bar, 20-bp 
palindrome; IR, 97-bp perfect inverted repeat (Schell et al., 2002).  
 
4. 1. 2: Genomic Adaptation of sugar metabolism. 
Bifidobacteria colonize the lower GIT, an environment poor in mono- and 
disaccharides because they are consumed by the host and microflora in the upper 
GIT. Although past work showed that B. longum utilizes a variety of plant-derived 
dietary fibers, such as arabinogalactans and gums (Salyers et al., 1977; Crociani  et 
al., 1994), the genome sequence suggests that this ability is much more extensive 
than previously anticipated, reflecting its adaptation to a special colonic niche. The 
genome contains a plethora of predicted proteins assigned to COGs in the 
carbohydrate transportmetabolism category, 8.5% of the total predicted 
proteins.This is 30% more than E. coli, Enterococcus faecium, L. lactis, B. 
halodurans, and B. subtilis. Numerous assignments were to COGs related to 
oligosaccharide hydrolysis and uptake such asthat to L-arabinofuranosidases, to 
glucosidase-related glycosidases, to glycosyl hydrolase family,  to sugar permeases, 
and that related to solute binding proteins. B. longum has 40 predicted glycosyl 
hydrolases whose predicted substrates cover a wide range of di-, tri-, and higher 
order oligo saccharides, including 2 xylanases, 9 arabinosidases, 2 galactosidases, 
neopullanase, isomaltase, maltase, inulinase (fructofuranosidase), 4 galactosidases, 
3 glucosidases, 3 hexosaminidases, and 3 mannosidases. To take full advantage of 
these enzymes and minimize crossfeeding of competitors, B. longum has 8 high-
affinity MalEFG-type oligosaccharide transporters (Cabral et al., 2001), more than 
in any other published prokaryotic genome. These likely help B. longum compete 
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for uptake of structurally diverse oligosaccharides released from plant fibers. 
Interestingly, many of the glycosyl hydrolases and oligosaccharide transporters are 
organized in 7 clusters that display a conserved modular architecture (Figure 4. 2). 
Each cluster consists of 5 predicted arabinosidases and a rare β-galactosidase 
homolog implying that its function is to release arabinose and galactose from 
internalized fragments of arabinogalactans and arabinoxylans. These fragments are 
probably generated by extracellular enzymes such as endoarabinosidase BL0183 
and endoxylanase BL1544 acting on larger, hemicellulosic  plant fibers in the GIT. 
The extent of B. longum’s metabolic adaptation to the GIT environment is further 
highlighted by cluster 6. In addition to the MalEFG-type oligosaccharide 
transporter and a glycosyl hydrolase, this cluster contains three α-mannosidases and 
an endo-NAc glucosaminidase, which are more commonly found in eukaryotes, 
where they remove the N-linked Man8-NAcGlc2 chains of glycoproteins (Cabral et 
al., 2001). Cluster 6 may function in catabolism of galactomannan-rich plant gums, 
that among major GIT inhabitants, are fermented only by B. longum (Salyers et al., 
1977) or more interestingly, in catabolism of glycans, glycoconjugates, or 
glycoproteins produced by epithelial cells of the colon. In support of this Hooper et 
al. (Hooper et al., 1999) showed in vivo that the GIT commensal Bacteroides 
thetaiotamicron induced mouse intestinal epithelium to produce specific glycans 
(oligosaccharides), which were metabolized by specialized bacterial enzymes for 
its own nutritional benefit, possibly enhancing colonization. 
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Fig. 4. 2: Oligosaccharide utilization gene clusters. Genes are represented by 
arrows. IS, insertion sequence; F and G, MalF-type and MalG-type permease 
subunits of ABC transporter, respectively; E and K, MalE-type solute binding 
protein and MalK-type ATP-binding protein of ABC transporter, respectively; R, 
LacI-type repressor; Arab, arabinosidase; β-Gal, β-galactosidase; α-Man, α-
mannosidase; β-Gal, β-galactosidase; GlycH, glycosyl hydrolase of unknown 
specificity; Isomal, isomaltase; NAc-Glc, N-acetyl glucosamindase; O157, ORF 
with homolog only in E. coli O157; X and Y, unique hypothetical proteins; 
LCFACS, long chain fatty acyl CoA synthetase; Est, possible xylan esterase; A, L. 
lactis phage infection protein homolog; B, oxidoreductase; C, phosphoglycerate 
mutase; f, fragment of AraE permease. Asterisks mark recent gene duplications 
(Schell et al., 2002). 
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4. 1. 3: Extracellular Components. 
Extracytoplasmic proteins and structures play critical roles in establishing and 
maintaining interactions between a microbe and its environment. In bifidobacteria 
these could mediate important functions affecting the host, such as adhesion, 
nutrient availability, immune system modulation, or pathogen inhibition. Among 
200 analysed proteins, 59 are apparently surface-associated lipoproteins, including 
26 solute binding proteins of ABC transporter systems. In agreement with the 
extensive ability of B. longum to scavenge nutrients from extracellular polymers, 
several enzymes for polymer fragmentation were predicted to be secreted: 2 
endoxylanases, 2 endoarabinosidases, an arabinogalactan β-galactosidase, a N-
acetyl β-glucosaminidase. Additionally, two putative secreted proteins displayed a 
clear Gram-positive cell-surface anchor motif and are very large and possibly 
involved in attachment to or degradation of xylan hemicellulose.The most 
intriguing protein with a cell-surface anchor motif is 30% identical to the major 
component of the type 2 glycopropotein-binding fimbriae of the oral cavity 
inhabitant Actinomyces naeslundii (Yeung iet al., 1998). Fimbriae have never been 
described or proposed for bifidobacteria, yet they are of great potential significance 
because they are cell-surface filamentsthat can mediate microbial adhesion to and 
colonization of epithelial, mucosal, or other host cell surfaces (Kubiet et al., 200). 
These additional cell-surface components include a sequence 31% identical to a 
fimbrial-associated sortase-like protein of A. naeslundii (Li et al., 1999), a 262-kDa 
protein with a repetitive glycine-rich sequence characteristic of some Rickettsial 
cell-surface proteins, and a predicted prepilin peptidase with 35% identity to the 
product of orfC, the fourth gene in the fimbrial biogenesis operon of A. naeslundii. 
Of all predicted secreted proteins, BL0108 is most remarkable because it displays 
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identity to proteins from the serpin family of protease inhibitors found 
predominantly in mammals. In 100 genomes searched, there are prokaryotic 
homologs of BL0108 only in the heterocyst-forming cyanobacterium Nostoc 
sp.However, unlike what is found in B. longum, this serpin homolog is not 
predicted to be secreted and is adjacent to a gene encoding a probable target 
protease. In eukaryotes, serpins control key steps in physiological regulatory 
cascades by inhibiting specific proteases (Silvermann et al., 2001). In some cases 
serpins play important roles in immune system evasion during pathogenesis, as in 
the case of a myxoma virus serpin that modulates host inflammatory response  
(Macen et al., 1993). 
 
4. 2: Serpins 
4. 2. 1: Serpins at a glance 
Serine proteinase inhibitors (Serpins) comprise a diverse group of proteins that 
form a superfamily including more than 100 members. The majority of Serpins act 
as protease inhibitors and are involved in the regulation of several proteinase-
activated physiological processes, important for the individual, such as blood 
clotting, complement mediated lysis, the immune response, glomerulonephritis, 
pain sensing, inflammation, pancreatitis, cancer, regulating fertilization, bacterial 
infection and viral maturation. Though the primary function of Serpins appears to 
be neutralizing serine proteinase activity, these polypeptides have also been found 
to play a role in extracellular matrix remodelling and cell migration. Examples for 
Serpins include, alpha 1-antitrypsin, antithrombin III, plasminogen activator 
inhibitor 1 (PAI-1) or plasminogen activator inhibitor 2. The Serpins known so far 
have been the subject of intensive Research and they all seem to have a common 
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characteristic loop, termed the reactive site loop (RSL), extending from the surface 
of the molecule containing the recognition sequence for the active site of the 
cognate serine protease. The specificity of each inhibitor is considered to be 
determined primarily by the identity of the amino acid that is immediately amino-
terminal to the site of potential cleavage of the inhibitor by the serine protease. This 
amino acid, known as the Pi site residue, is considered to form an acyl bond with 
the serine in the active site of the serine protease. The Serpins seem to act as 
"suicide inhibitors" forming a 1:1 stochiometric complex with the target proteinase, 
thus blocking their activity. According to recent data it has been indicated that the 
inhibitor is cleaved in the reactive center and that the complex is most likely 
trapped as a covalent acyl-enzyme complex. Numerous signaling pathways in 
higher organisms, such as apoptosis, inflammation, blood clotting, and others, 
involve proteolytic events as mediators of signal initiation, transmission, and 
termination. Substrate specificity of the involved proteases and a tight regulation of 
their activation and inhibition are essential regulatory mechanisms of temporal and 
spatial control in proteolytic signaling. Serpins (serine protease inhibitors) represent 
a large class of polypeptide serine protease inhibitors that are involved in regulation 
of a wide spectrum of protease-mediated processes (Gettins P. G., 2002; Silverman 
et al., 2001). Serpins are widely distributed in higher eukaryotic organisms and are 
also found in some viruses where they appear to modulate virus-host interactions 
and viral infectivity (Gettins P. G., 20021). Thirty-four serpins identified in the 
human genome belong to nine different phylogenetic clades in the currently 
adopted serpin classification (Silverman et al., 2001). Notably, some members of 
the serpin superfamily, such as ovalbumin, angiotensin, and others (Hunt and 
Dayhoff, 1980; Doolittle R. F., 1983), do not act as protease inhibitors but rather 
perform non-inhibitory biological functions despite a clear evolutionary 
relationship and an almost identical native fold. These non-inhibitory members of 
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the serpin superfamily appear to be incapable of the structural rearrangement 
required for protease inhibition (Wright et al., 1990). Recently serpins were 
identified in bacteria and archea expanding their presence to all major domains of 
life ( Schell et al., 2002). This observation suggests that the unique serpin fold and 
the associated inhibitory mechanism may have originated at the early stages of 
evolution. Very little is currently known about the function of serpins in 
prokaryotes (Roberts et al., 2004;). The sequence-based analysis suggests that 
prokaryotic members of the serpin superfamily are functional protease inhibitors, 
and a serpin from Thermobifida fusca, thermopin, was shown to inhibit 
chymotrypsin albeit by means of an unconventional cleavage site (Irving et al., 
2003). Thermopin is, however, unusual because of its ability to function at elevated 
temperature, whereas conventional serpins are prone to polymerization at higher 
temperature due to the metastable nature of their native fold (Fulton et al., 2005).  
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Class 
 
Type 
 
Action 
 
Name 
 
Research 
 
 
Inhibitory 
 
 
Proteases 
inhibitors 
 
Control of  
proteolytic          
cascades  
 
Coagulation and 
inflammation 
 
Antithrombin 
 
 
Antitrypsin 
 
Antithrombin      
deficiency results                 
in thrombosis  
 
Antitrypsin deficiency 
causes emphysema 
 
 
Non-inhibitory 
 
Hormone  
carriage proteins  
 
Tumor  
suppressor genes    
 
Hormone           
binding 
 
Apoptosis 
induction 
 
Cortisol     
binding globulin 
 
Maspin 
 
Prevent metastasis in  
breast and prostate 
 
Inhibits motility and 
invasion in Caco-2       
cells in culture 
Tab 4. 1: Serine proteases inhibitors in human plasma.  
 
 
4. 2. 2: Serpins in Bifidobacterium longum 
Serpin was identified in the genome of Bifidobacterium longum NCC2705, an 
infant-derived strain of bifidobacteria (Schell et al., 2002). The sequencing of the 
B. longum genome revealed a genetic makeup that reflected a remarkable 
adaptation of this organism to the GIT environment. Intriguingly, the genome-wide 
search for predicted secreted proteins identified a serpin-like molecule encoded by 
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this microorganism (Schell et al., 2002). To explore the physiological role of this B. 
longum protein in the GIT environment and its possible function in host-bacterium 
cross-talk, it has been performed  a biochemical characterization of this hypothetical 
serpin. Despite the extensive knowledge about the role of serpins in regulation of 
the protease-mediated processes in higher multicellular eukaryotes, very little is 
currently known about their function in prokaryotes. The presence of serpins in 
bacteria and archea implies that this protein superfamily is likely to have originated 
before the separation of the major branches of life. However, serpins are rather 
sparsely present among the prokaryotes indicating that they are either easily lost 
when not essential for survival or alternatively that they may have been acquired by 
prokaryotes as the result of horizontal gene transfer. Most of the serpins from 
unicellular organisms are distantly related to the serpins from higher organisms and 
do not belong to any of the existing serpin clades. This also applies to the B. 
longum serpin, which is an orphan in the current serpin classification. These 
observations suggest that if unicellular serpins were acquired by horizontal gene 
transfer, such events would have occurred independently for different serpins, and 
the original multicellular donors of these genes are not present in the existing 
genomic databases (Roberts et al., 2004). B. longum serpin inhibits elastase-like 
serine proteases following conventional cleavage of the P1-P1'. When combined 
with the primary sequence analysis of the unicellular serpins (Roberts et al., 2004) 
the conventional inhibitory activity of the B. longum serpin suggests that the 
majority of serpins identified in unicellular genomes are inhibitory proteins with the 
inhibition mechanism identical to that of the inhibitory serpins in higher 
multicellular eukaryotes. Recent results indicate that the inhibitory function of 
serpins either evolved very early in the course of evolution or (in the case of the 
horizontal gene transfer scenario) that the inhibitory function of the serpins was 
predominant in the multicellular organims by the time horizontal gene transfers 
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occurred. The B. longum NCC2705 serpin is an efficient inhibitor of pancreatic 
elastase and neutrophil elastase, which appears relevant given that bifidobacteria 
are likely to be in contact with both of these enzymes in the gastrointestinal tract. 
Pancreatic elastase is a digestive enzyme secreted by the acinar cells in the 
pancreas, and unlike other pancreatic enzymes it is very stable during the passage 
through the intestine as its activity can readily be detected in the feces (Sziegoleit et 
al., 1989). Protease inhibitors produced by bacteria may act to protect them against 
exogenous proteases and to provide an important competitive advantage. For 
example, secreted protease inhibitors identified in Bacillus brevis and Privotella 
intermedia are thought to protect these organisms against external proteolytic attack 
(Shiga et al., 1995; grenier D., 1994), while the periplasmic protease inhibitor of E. 
coli ecotin was shown to protect these bacteria against neutrophil elastase (Eggers 
et al., 2004).  The healthy commensal flora required for normal intestinal function 
involves a delicate homeostatic balance on the mucosal surfaces of the 
gastrointestinal tract manifested in the apparent tolerance of the immune system 
toward commensal microorganisms, whereas pathological species are met with a 
vigorous and destructive immune response (Sansonetti P. J., 2004). Given the 
reported immunomodulatory properties of bifidobacteria, B. longum serpin 
inhibition of human neutrophil elastase is of particular interest, because the release 
of neutrophil elastase and other granule proteases by activated neutrophils at the 
sites of intestinal inflammation represent an important mechanism of innate 
immunity (Burg and Pillinger, 2001; Reeves et al., 2002). Massive recruitment and 
activation of neutrophils in the intestine are triggered during intestinal inflammation 
caused by pathogenic bacteria but can also be a result of a pathological immune 
activation as observed in the inflammatory bowel disease. Identification of a novel 
neutrophil elastase inhibitor produced by the commensal bacterium B. longum 
suggests an intriguing possibility that the release of a neutrophil elastase inhibitor at 
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the sites of intestinal inflammation may be beneficial for reducing the deleterious 
effects of the HNE (human neutrophil elastase) activity, similar to the way the 
pathological tissue damage associated with the excessive HNE activity is attenuated 
by 1-antitrypsin, the physiological HNE inhibitor in the blood plasma. Further 
investigation of the B. longum adaptation mechanisms to the mammalian GIT is 
required for better understanding of the potential role of the B. longum serpin in the 
interaction of this bacterial species with its host.  
 
 
 
Chapter 5: Intestinal cell model  
 
 
5. 1: Establishment of a pig cell model 
 
 
5. 1. 1: Overview 
To study the influence of protective and probiotic bacteria on their interactions The 
functional mammalian cell models to be established will mimic the intestinal tract 
of pigs. Cell lines will be used for the functional cell model. The most common 
cells in the intestinal epithelium are enterocytes. They are polarised cells with a 
distinct apical and basolateral cytoplasmatic membrane. Enterocytes are separated 
from one another by junctions, which form a tight epithelial barrier. Good in vitro 
cell models must satisfy two basic requirements: retention of tissue characteristics 
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to support interpretation of results for the in vivo situation and availability and easy 
handling for high-throughput testing. Cell culture models play a pivotal role in 
laboratory research of various fields. Appart of existance of many various cell 
lines, there is a substantial lack of good intestinal cell culture models. In spite of the 
fact, that human colon tumorigenic cell lines, like Caco-2, are widely used as a 
model of a small intestine, such cell lines do not represent the normal small 
intestine of the man. It is accepted, that pig is much better animal model than 
rodents in human research , therefore we have established a functional cell model 
of an adult pig small intestine, consistent of two pig intestinal epithelial cell lines 
(PSI and CLAB) and macrophages from the pig peripheral blood (PoMac). All 
newly established cell lines were spontaneously transformed to the continous cell 
line and characterised by morphological, immunochemical and functional 
characteristics. Results obtained proved, that the established functional cell model 
of the pig small intestine can be successfully used in various studies involving the 
small intestinal tract, as well as in studies of local or systemic immunity (Cencic et 
al., 2006). 
 
5. 1. 2: Epithelial cells 
Are the most common epithelial cells in the intestinal epithelium, responsible for 
majority of the absorption of nutrients and drugs. They are polarised cells with 
distinct apical and basolateral cytoplasmatic membrane. Enterocytes are separated 
among themselves by tight junctions and form tight epithelial barrier (Figure 5. 1). 
Transport of signalling molecules or pathogens themselves across the intestinal 
epithelial barrier towards underlying mucosal immune system is a complex and 
dynamic process incuding various functional pathways (transcellular and 
paracellular transport, transport via carriers and endocytosis) (Balimane et al., 
2000). 
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Fig. 5. 1. Enterocyte epithelial cell representation outlining cell polarity with three 
domains. (Original drawing of the author). 
 
5. 1. 2: Monocyte cells 
Monocytes play important roles in both innate and adaptive immune responses, 
killing microbial pathogens and tumour cells, and exerting immunoregulatory 
functions through cytokine production and processing and presentation of antigens 
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to lymphocytes. These cells arise from haemopoietic precursors in the bone 
marrow, and after 2–3 days in the blood migrate into different tissues, where they 
undergo further differentiation to become tissue-resident macrophages (Gordon et 
al.,1988). Under specific culture conditions in vitro, monocytes can differentiate 
into macrophages in the presence of serum or macrophage colony-stimulating 
factor (Chapuis et al., 1997; Palucka et al., 1998) or into dendritic cells when 
cultured with granulocyte–macrophage colony-stimulating factor and interleukin-4 
(IL-4) (Sallusto and Lanzavecchia, 1994; Banchereau et al., 2000). Although the 
heterogeneity of monocytes is not as obvious as that displayed by macrophages, in 
the human several monocyte subpopulations differing in phenotype and functional 
capabilities have been reported. Ziegler-Heitbrock et al. identified a minor 
population of CD14+ CD16+ monocytes that represents around 10% of the total 
monocyte population and exhibits proinflammatory features, producing high 
amounts of tumour necrosis factor-α (TNF-α) but no or little IL-10, while the major 
population of CD14+ CD16− monocytes produces both types of cytokines (Passlick 
et al., 1989; Ziegler-Heitbrock H.W., 1996). Moreover, within the CD14+ CD16+ 
monocytes, the M-DC8+ marker identifies a subset with capacity to differentiate in 
vitro into potent dendritic cells (de Baey et al., 2001). Two monocyte subsets have 
been characterized by Grage-Griebenow et al. based on the expression of CD64 
(Grage-Griebenow et al., 1993). Monocytes lacking CD64, comprise less than 10% 
of the whole monocyte population and display higher capacity for antigen 
presentation than the predominant CD64+ monocytes which show higher 
phagocytic activity and produce more reactive oxygen intermediates. Simultaneous 
analysis of CD16 and CD64 allows a further division into four phenotypically and 
functionally different subsets. Out of them, CD64+ CD16+ monocytes exhibit 
dendritic-cell-like high antigen-presenting capacity, while CD64− CD16− 
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monocytes resemble the plasmacytoid dendritic cell blood precursors with high 
interferon-α (IFN-α) producing capacity (Grage-Griebenow et al., 2000 and 2001).  
 
5. 1. 3: Functional polarity 
The intestinal epithelium, the site of interface with probiotics as well as other 
luminal constituents, conducts several functions required for intestinal homeostasis. 
Among these, the ability to form a barrier to oppose permeation of solutes into the 
lamina propria, and to regulate fluid and electrolyte transport, have been studied 
extensively. Alterations in both barrier and transport functions are common 
sequelae of a variety of digestive disorders, and may underlie diarrhoeal symptoms. 
Moreover, both transport and barrier functions, and epithelial turnover and 
differentiation, are known to be regulated in part by signal transduction events 
originating from the epidermal growth factor receptor (EGFr) (Buret et al., 1999). 
EGFr activation has been shown to cause redistribution of actin filaments in the 
apical zone of epithelia and to evoke changes in tight junctions and the 
cytoskeleton that are associated with an increase in transepithelial resistance (TER) 
and hence barrier function (Galan et al., 1992; Resta-Lenert and Barrett, 2005). 
Unregulated inflammation of the gastrointestinal tract (GIT), e.g., during active 
periods of inflammatory bowel diseases, causes an increased permeability of the 
epithelium, leading to deterioration of the epithelial barrier function (Madsen et al., 
2001). Consequently, luminal bacteria and luminal substances (e.g., bile salts and 
gastric or pancreatic enzymes) are allowed access into the underlying tissue and 
bloodstream of the host. Several studies have focused on the molecular 
mechanisms responsible for increased epithelial permeability (Nusrat, et al., 2001; 
Otte and Podolsky, 2004) and have observed that it is linked to weakening of the 
tight junctions. Tight junctions establish a polarity of the epithelial cell layer by 
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forming a seal between adjacent epithelial cells, thereby separating the luminal 
compartment from the basolateral surface (Schneeberger and Lynch, 2004). 
Treatment with probiotic bacteria may prevent or reverse increased permeability of 
the epithelium and act antagonistically towards pathogens (Otte and Podolsky, 
2004; Resta-Lenert and Barrett, 2003). A method for attaining the permeability in 
vitro includes the measurement of electrical physical resistance to determine the 
transepithelial electrical resistance (TER). 
 
 
 
 
5. 2: Interaction with probiotic bacteria 
 
5. 2. 1: ROS and Nitric oxide production 
Whereas reactive oxygen species (ROS) are classically thought of as cytotoxic and 
mutagenic or as inducers of oxidative stress, recent evidence suggests that ROS 
play a role in signal transduction. ROS are implicated in stimulation or inhibition of 
cell proliferation, apoptosis, and cell senescence (Burdon R., 1995;  Gansauge et 
al., 1997). Whereas activated phagocytes produce very high levels of O2- and H2O2 
that participate in host defence, many other cell types also generate ROS, albeit 
generally at lower levels  (Burdon R., 1995;  Cross and Jones 1991; Szatrowski and 
Nathan, 1991). The function of non-phagocytic ROS generation is unclear, but in 
some cases correlates with cell proliferation and activation of growth-related 
signalling pathways. Intriguingly, significant ROS generation is seen in cell lines 
derived from human cancers (Szatrowski and Nathan, 1991).The enzymatic origin 
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of ROS in phagocytes is established, but its origin in non-phagocytic cells is less 
clear. The phagocyte respiratory burst oxidase, an NADPH-dependent 
multicomponent enzyme, generates O2-, with secondary generation of H2O2 (Babior 
B. M., 1995). Whereas some ROS in non-phagocytes is of mitochondrial origin 
(Williams et al., 1998 ), ROS production in many cells is blocked by inhibitors of 
the phagocyte NADPH oxidase. 
 
5. 2. 2: Immune response 
It has been previously reported that the bifidobacteria can enhance host 
immunological functions via the activation of macrophages and lymphocytes 
(Hatcher and Lambrecht, 1993; Sekine et al., 1994; Kirjavainen et al., 1999), 
antibody synthesis (Link-Amster et al., 1994; Fukushima et al., 1999), and the 
proliferation of T- and B-cells (Takahashi et al., 1993; Kang et al., 1994). The 
intake of bifidobacteria has been demonstrated to enhance resistance against 
infection by pathogenic organisms (Sasaki et al., 1994; Nomoto, 2005), and may 
also help in the prevention of cancer (Rafter, 1995; Sekine et al., 1995). These 
immunopotentiating activities have been suggested to be mediated via interactions 
occurring between immune cells and intact bacterial cells or their components, 
including peptidoglycan, teichoic acid, and/or cellfree extract (Ouwehand et al., 
1999; Amrouche et al., 2006). Activated macrophages evidence the capacity to 
induce the production of several cytokines which perform a pivotal function in a 
variety of immune responses. A variety of studies have demonstrated that viable or 
heat-killed Lactobacillus and Bifidobacterium species, as well as certain of their 
cell components, are capable of stimulating the production of hydrogen peroxide, 
nitric oxide, and cytokines such as interleukin (IL)-6 and tumor necrosis factor 
(TNF)-α in macrophage cell lines (Miettinen et al., 1996; Park et al., 1999; Tejada-
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Simon and Pestka, 1999; Cross et al., 2004). Antigen-presenting cells (APCs), such 
as monocytes, macrophages, and dendritic cells (DCs), are responsible for detecting 
microbes and presenting their antigenic structures to T cells, thus eliciting acquired 
immune responses. In addition, monocytes and macrophages kill microorganisms 
by phagocytosis and produce proinflammatory cytokines. DCs are more potent 
APCs with a special ability to prime naïve T lymphocytes to novel protein antigens. 
Upon activation initiated by signals from microorganisms or from other cells in the 
tissue, DCs migrate to the regional lymph nodes. During this process, they undergo 
maturation, up-regulate costimulatory molecules, and produce cytokines, which 
make them qualified to activate naïve T cells. Monocytes and DCs recognize 
conserved motifs in bacteria through Toll-like receptors (TLRs), along with other 
pattern recognition receptors. The triggering of APCs through TLRs initiates a 
signal transduction cascade that culminates in the activation of transcription factors, 
such as NF- B, which leads to secretion of cytokines and expression of 
costimulatory molecules. Furthermore, CD14 plays an essential role in the response 
to microbial components from both gram-positive and gram-negative bacteria 
(Karlsson et al., 2004). Purified components of microbes have been used to study 
the specificity of individual TLRs. The gram-negative bacterial compound 
lipopolysaccharide (LPS) is recognized by TLR4 (Hoshino et al., 1999; Schroder et 
al., 2003). TLR2 recognizes many different microbial compounds, including 
peptidoglycan and lipoproteins from both gram-positive and gram-negative 
bacterial cell walls.  However, the survival and colonization of orally-administered 
probiotic bacteria in the gastrointestinal environment is generally poor, as these 
bacteria are susceptible to low acidic pH in the stomach and to bile acid and 
pancreatic juice within the small intestine (Marteau et al., 1992; Clark and Martin, 
1994). Presently, there is no clear understanding regarding the molecular or cellular 
basis for immunomodulation by bifidobacteria forced to withstand gastrointestinal 
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conditions. The objective of the current study was to compare the in vitro effects of 
undigested whole cells and enzymatically-digested bifidobacteria on the induction 
of nitric oxide and IL-1β, IL-6, IL-12, and TNF-α in a RAW 264.7 murine 
macrophage cell line. 
 
 
Fig. 5. 4: Schematic representation of cytokines sketching monocytes 
differentiation. (Original draw of the author).  
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Part two: Materials and Methods 
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Chapter 6: Materials and Methods, section I 
 
6. 1: Bacterial strains 
 
All isolates studied were B. longum. Strains B12, B18 and B2990 were obtained 
from the culture collection of the Microbiology area of the Department of 
Agroenvironmental Science and Technology (University of Bologna, Italy). The 
bacteria were cultured in TPY broth (Tryptone, Peptone, Yeast) (Scardovi, 1986; 
Modesto et al., 2003) in anaerobic jars at 37°C (Merck, Darmstadt, Germany). 
Bacteria were harvested by centrifugation at 2500 rpm for 15 min at 20°C. After 
washing in phosphate-buffered saline (PBS) pH 7.4, at 25°C, bacterial cells were 
resuspended in the same buffer. Cell counts in the bacterial suspensions were 
estimated by optical density at 600 nm absorbance (Pharmacia Biotech, 
Piscataway, N); the O.D.600 aimed was 0.8, that match a final concentration of  108 
÷109 cells/ml. 
 
6. 2: Cell line 
 
Caco-2 (human colon adenocarcinoma) cells were from American Type and Tissue 
Collection (ATCC). Caco-2 cells were routinely grown in DMEM Dulbecco’s 
modified Eagle’s medium (Sigma-Aldrich, St. Louis, MO) supplemented with 10% 
(w/v) heat-inactivated (30 min, 56°C) fetal bovine serum (FBS) (Cambrex, 
Baltimore, MD), 1% (w/v) L-glutamine (Cambrex) and 100U/mL penicillin and 
100µg/mL streptomycin. Cells were cultured in 25-cm2 FALCON flasks in an 
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anaerobic jar at 37°C in an atmosphere with a 5% concentration of CO2, generated 
by a special catalyst (GenBox, Biomerieux, Rhône, France). They were refed every 
day with 5 ml of fresh medium and were subcultured serially when approximately 
80% confluent. For all the assays reported, monolayers of Caco-2 cells were 
prepared in a Falcon 6-wells plates (BD Bioscience, Bedford, MA) with 2 x 105 
cells/cm2, incubated at 37° C in an atmosphere with a 5% concentration of CO2 . 
The cultures were used after 15 days of post confluent growth (Figure 6.1). 
 
 
Fig. 6. 1: a) Monolayer of Caco-2 cell line after 15 days of post confluent growth 
observed with a light microscope under 1000x and b) 4000x magnification. Cells 
were grown in DMEM medium (Sigma-Aldrich) with 10% (w/v) FBS, 1% (w/v) L-
glutamine and antibiotics. Cells were cultured in 25-cm2 FALCON flasks in an 
anaerobic jar at 37° C with a
  
5% CO2. Bar indicates 
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6. 3: Adhesion 
 
6. 3. 1: Adhesion assay on Caco-2 cell line. 
Adhesion assays were carried out following a previously described protocol (Del 
Re et al., 2000). The cell monolayers were washed twice with phosphate-buffered 
saline (PBS) before the adhesion test. Bacterial strains were grown for 72 h at 37° 
C in (TPY) agar plates, colonies were collected in TPY broth, centrifuged and 
resuspended in DMEM at a concentration of 108 bacteria/ml. Aliquots of this 
suspension (2,5 ml) were added to the tissue culture dishes and incubated for 2 h at 
37° C with 5% of CO2 concentration. After incubation, the monolayers were 
washed five times with PBS, fixed with methanol, Gram stained and counted, using 
20 randomized microscopic fields per dish. Adhesion was measured as number of 
bacterial cells adhering to monolayers of Caco-2 cells. Bacterial strains were 
designed as non adhesive (Adh-), when fewer than five bacteria adhered to 100 
cells; adhesive (Adh), when from six to 40 bacteria adhered to 100 cells and 
strongly adhesive (Adh+), when more than 40 bacteria adhered to 100 cells. 
 
6. 3. 2: Aggregation assays 
Aggregation assays were performed with a previously described protocol (Del Re 
et al., 2000). Bacteria were grown at 37° C for 24 h in TPY broth in anaerobic jars. 
The cells were harvested by centrifugation and resuspended in PBS to 0.5 optical 
density (O.D.) units at 600 nm. Two ml bacterial suspension were placed in each 
tube and centrifuged. The cells were then resuspended in their culture supernatant 
fluids. After incubation at 37° C for 2 h in anaerobic jars, 1 ml of the upper 
suspension was transferred to another tube and the O.D. at 600 nm measured. 
Aggregation was expressed as 1 - (O.D.600 upper suspension/O.D.600 total 
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bacterial suspension) x 100. The strains were defined as strongly autoaggregating 
(Agg+), when displayed an high aggregation percentage (80%) and aggregate 
immediately, forming a precipitate and resulting in a clear solution; non 
autoaggregating (Agg-), when were unable to autoaggregate (10%) and produce 
constant turbidity; and autoaggregating (Agg+/-), when showed a percentage 
around 50% and its suspension has both turbidity and precipitate. 
 
 
6. 4: Apoptosis  experiments 
 
6. 4. 1: Apoptotic induction 
The cultures of B. longum were harvested by centrifugation after a 24 hours 
growth. After washing in PBS, the supernatants were discarded, the pellets 
resuspended in the same buffer and directly seeded onto the Caco-2 layer at a 
density of 106-108 bacteria/ml. The induction of apoptosis was performed within 3 
hours of incubation time, at 37° C in anaerobic jars with a 5% CO2 concentration. 
Then, the samples were washed in gentle shaking for five times with PBS pH 7,4 at 
25° C to remove all bacterial cells; and finally treated with trypsin-EDTA x 4Na 
solution (Sigma-Aldrich, St. Louis) to release Caco-2 cells. Trypsin was inactivated 
with 500 µl of DMEM supplemented with FBS 10% (w/v). The suspensions were 
recovered and assayed. 
 
6. 4. 2: DNA purification and analysis 
DNA purification was carried out using a DNA purification kit (Roche Diagnostics 
GmbH, Mannheim, Germany), according to manufacturer instructions. The eluted 
DNA, 10 µg (wt/v), was collected and stored at  -20°C or live assayed. The purified 
DNA was used to perform a standard gel electrophoresis on a 1% (w/v) TBE (Tris-
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Borate EDTA solution) low melting agarose gel (Bio-Rad, Richmond, CA), 
buffered with 1x TBE solution, for two hours at 85 V. The DNA pattern was 
visualized with an UV transilluminator (Bio-Rad) and photographed (Nikon, 
Tokyo, Japan). The purified DNA of Caco-2 treated with campothecin (Roche), an 
apoptotic inducer that led to a typical DNA ladder, and the purified DNA of Caco-2 
cells incubated for 3 hours with the sole PBS solution, were used as positive and 
negative controls of DNA fragmentation, respectively. 
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Chapter 7: Materials and Methods, section II 
 
7. 1: Bacterial strains 
Bifidobacterium longum strains B12, B18 and B2577 were obtained from the 
culture collection of Microbiology area of Department of Agroenvironmental 
Science and Technology (University of Bologna, Italy). Lyophilised bacteria were 
recovered in TPY (Tryptone, Peptone, Yeast) broth (Scardovi, 1986) in anaerobic 
jars at 37 °C (Merck, Darmstadt, Germany) and cultured in MRS (Man-Rugosa-
Sharpe) medium (Oxoid Ltd., Hampshire, U.K.) supplemented with 0.05 % (w/v) 
L-cysteine-HCl. MgCl2 (100 mM), CaCl2 (10 mM), and the appropriate sugars 
were added to MRS to regenerate bacteria after electro-transformation protocol. 
Escherichia coli XL-1 and SOLR strains were purchased from the supplier 
(Stratagene, La Jolla, CA.) and were routinely grown in LB (Luria-Bertani) 
medium, at 37 °C under agitation. Tetracycline (12.5 µg/ml), ampicillin or 
spectinomycin (50 or 75 µg/ml) were added when necessary, as well as X-Gal (100 
µg/ml) and IPTG (10 µg/ml), or 10 mM MgSO4 and maltose (0.2 % w/v) (Table 7. 
1). 
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7. 2: Screening for serpin gene 
 
7. 2. 1: Genomic library 
To determine the titer of the library XL1-Blue MRF’ cells were diluted to an OD600 
of 0.5 with sterile 10 mM MgSO4. and the following components were mixed: 1 µl 
of the library aliquot and 200 µl of XL1-Blue MRF’ cells at an OD600 of 0.5 and 1 
µl of a 1:10 dilution of the library aliquot and 200 µl of XL1-Blue MRF’ cells at 
the same OD600. For amplified library titering, the amplified phage stock was first 
dilute in SM buffer by the following amounts: 1:10,000, 1:100,000, 1:1,000,000. 1 
µl of each dilution was added to 200 µl of host cells. The phage and the bacteria 
were incubated at 37°C for 15 minutes to allow the phage to attach to the cells. 
Then the following components were added: 2–3 ml of NZY top agar (melted and 
cooled to ~48°C), 15 µl of 0.5M IPTG (in water), 50 µl of X-gal [250 mg/ml (in 
DMF)]. Everything was immediately plated onto dry, prewarmed NZY agar plates 
and incubated at 37°C. Plaques were visible after 12 hours. Background blue 
plaques were approximately < 1× 105 pfu/µg of arms, while white recombinant 
plaques were 10–100-fold above the background. 
 
7. 2. 2: Sib-selection 
In order to amplify serpin-encoding gene, a genomic library of B. longum B12 was 
screened following a non radioactive method previously described (King, 2000). 
Library DNA was used as template in a PCR reaction with 0.5 units of HerculaseII-
TopFusion enzyme (Stratagene), 250 µM of each dNTP and 34 pmol of both S1f 
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and M13uni primers (Table 1). The PCR profile was as follow: 96°C for 2 min 
followed by 30 cycles (each cycle: 95 °C for 20 s, 53 °C for 20 s, 72 °C for 40 s) 
and a final extension at 72 °C for 3 min. PCR screening was repeated for three 
cycles and positive phages lastly obtained were recovered to be in vivo excised with 
fresh M13 phages co-infecting E. coli SOLR strain, according to the supplier’s 
instruction (in vivo excision protocol Stratagene). 
 
Fig. 7. 1: Bifidobacterium longum Serpin gene sequence: accession number: 
DD87853. (Shiffrin et al., 2004). 
 
7. 2. 3: In vivo excision 
The ExAssist helper phage was supplied in 7% dimethylsulfoxide (DMSO) and 
stored at -80°C. The helper phage was stored for short periods of time at -20°C or 
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4°C. The helper phage prior to each use was titered of approximately 1010 pfu/ml. 
Positive phages lastly obtained were recovered to be in vivo excised with fresh M13 
phages co-infecting E. coli SOLR strain, according to the supplier’s instruction (in 
vivo excision protocol Stratagene). To determine the titer [in plaque-forming units 
per ml (pfu/ml)], use the following formula: 
 
 
where the volume plated (in microliters) refers to the volume of the helper phage 
solution added to the cells. The titer of the supernatant were included between 7.5 × 
1010 and 1.0 × 1012 pfu/ml for ExAssist helper phage or between 1.0 × 1011 and 1.0 
× 1012 pfu/ml for VCSM13 helper phage. 
 
7. 3: Cloning 
 
7. 3. 1: Fragment rescue and analysis 
PBluescript plasmid from positive clones was rescued and purified with columns 
(Nucleo Spin Plasmid, MN, Macherey Nagel GmbH & Co. Kg. Duren, Germany). 
To amplify serpin encoding gene, the same plasmid was used as template DNA in a 
PCR reaction with 1.25 units of Pfu DNA Polymerase (Fermentas GmbH, St. Leon 
Rot, Germany), using 250 µM of each dNTP and 36 pmol of both S1fBamHI and 
M13uni primers (Table 1).The PCR profile was as follow: 96 °C for 1 min followed 
by 26 cycles (each cycle: 95 °C for 30 s, 53 °C for 30 s, 72 °C for 2 min and 30 s) 
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and a final extension at 72 °C for 5 min. PCR products were run on a 1.8 % 
TopVision™ Low Melting agarose gel (Fermentas) and the appropriate band, 
approximately 0.9 kb, was isolated and purified with columns (Nucleo Spin Gene, 
MN).  
 
 
 
 
Strains, plasmids,  
oligonucleotides 
Description Source of reference 
Bifidobacterium longum 
     B12 
     B18 
     B2577 
     B112  
     B118 
 
Escherichia coli 
XL-1 Blue MRF’ 
     SOLR 
Plasmids 
     pUC18Serpin 
     pRM2 
     pRM3 
 
Oligonucleotides 
     S1f 
     S1r 
     M13uni 
     S1f-BamHI 
 
 
 
Probiotic strain (wild type) 
Probiotic strain (wild type) 
B2577 strain harbouring pRM2 
B12 strain harbouring pRM3  
B18 strain harbouring pRM3  
 
 
Cloning host 
In vivo excision protocol 
  
 
pUC18 with S1f/M13 insert  
pGEM-5Z with pMB1 of B2577 Spr 
pRM2 with S1f/M13 insert  
 
 
 
5’-CAACTGAACGAACTGCTGG 
5’-AGACGGTGTTGATGATGGAC 
5’-TGTAAAACGACGGCCAGT 
5’-GGTCTAGACAACTGAACGAACTG 
 
 
 
(Scardovi 1986) 
(Scardovi 1986) 
(Missich et al., 1994) 
This work 
This work 
 
(Bullock et al., 1987) 
Stratagene 
 
(Missich et al., 1994) 
This work 
This work 
 
 
 
This work 
This work 
MWG, Ebersberg, DE 
This work 
Tab. 7. 1: Strains, plasmids and oligonucleotides used in this study. 
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7. 3. 2: Vector construction 
Serpin fragment was digested with BamHI and EcoRI enzymes (Fermentas) and 
purified, then ligated with purified and digested pRM2 or with pUC18 (Fermentas), 
generating respectively pRM3 and pUC18Serpin as positive control. Before 
ligation both plasmids were incubated with 1.2 units of alkaline phosphatase 
(Fermentas) to avoid plasmid self-ligation. Ligation was executed by 2 units of T4 
DNA ligase (Fermentas) with approximately 86 ng of vector and 262 ng of insert as 
according to the supplier’s instruction; its success was confirmed by 1.2 % agarose 
gel electrophoresis. General recombinant DNA techniques were performed by 
standard procedures (Sambrook et al., 1989).  
 
7. 4 Transformation 
 
7. 4. 1: Escherichia coli  
The product of ligation was then integrated chemically in E. coli XL-1 competent 
cells using TransformAid™ Bacterial Transformation Kit according to the 
supplier’s instruction (Fermentas). Transformants were selected after plating in LB 
agar supplemented with 50 µg/ml ampicillin, 100 µg/ml X-Gal (5-bromo-4-chloro-
3-indolyl-β-D-galactopyranoside) (20 mg/ml in N,N-dimethylformamide) and 10 
µg/ml of 0.1 M IPTG (isopropyl-β-D-thiogalactopyranoside) for detection of 
ampicillin resistance and β-galactosidase activity. Transformation efficiency 
(expressed as the number of transformants/µg of plasmid DNA) for E. coli XL-1 
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cells with pRM3 plasmid ranged 1 x 106 transformants/µg of pRM3. Plasmid DNAs 
of 20 blue recombinant clones were isolated and screened to confirm plasmid 
integrity via a colony PCR with Pfu enzyme (Fermentas). 
 
7. 4. 2: Bifidobacterium longum 
Bifidobacterium longum BuSc B12 and BuSc B18 (Scardovi, 1986) were electro-
transformed with purified pRM3 plasmid DNA. All experiments were carried out 
with a Bio-Rad Gene Pulser apparatus equipped with a Pulser Control nit (Bio-Rad 
Laboratories, Hercules, CA) at a capacitance of 25 µF, using cuvettes with 0.2 cm 
inter-electrode distance. The use of different sugars supplementing MRS medium 
was executed to obtain the best electroporation efficiency. A stationary phase (18 
h) culture of recipient strain grown in MRS medium, eventually enriched with one 
of the following sugars: raffinose 0.8 mol/l, glucose 0.7 mol/l, lactose 0.5 mol/l was 
inoculated (5 % inoculum) with 120 ml of same medium. B. longum strains were 
harvested at early-log phase (0.5 x 109 CFU/ml), washed with Na-phosphate buffer 
5 mmol/l pH 7, resuspended in NaMR buffer (Na2PO4 5 mmol/l, MgCl2  1 mmol/l, 
raffinose 0.3 mmol/l, pH 4.8), then aliquoted and stored at – 135 °C. Cell 
suspension (80 µl) was mixed with 0.25 µg of plasmid DNA, cooled 5 min on ice, 
transferred into an electrocuvette and rapidly pulsed for a time constant between  
3.8 and 4.3 ms. The apparatus was set at 200 Ω resistance and at voltages not 
exceeding 12.5 kV/cm. Cells were immediately recovered with 800 µl of MRS 
medium supplemented with sugars, including with 0.5 mmol/l ribose. After 4 hours 
of growth in regeneration broth, different aliquots were plated onto MRS agar with 
the right sugar and 50 µg/ml ampicillin and 75 µg/ml spectinomycin. The plates 
were incubated routinely for 72  h. Finally B. longum transformants colonies for 
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ampicillin and spectinomycin resistance were passed via replica plating method to 
MRS agar plates with X-gal and IPTG.  
. 
 
7. 5: Serpin detection 
 
7. 5. 1 PCR analysis 
Several transformants blue colonies were screened using their plasmid DNAs as 
template in a PCR reaction with primers S1f and S1r. To confirm biochemical 
screening of E. coli XL-1 and B. longum B112 and B118 transformants, a colony 
PCR was performed using 1 unit of Pfu DNA Polymerase (Fermentas), 250 µM of 
each dNTP and 34 pmol for both S1f and M13uni primers (Table 1). In order to 
confirm the integrity of cloned Serpin gene in pRM3 from positive transformants B. 
longum, 10 ng of rescued pRM3 were used as template in a PCR reaction with 0.5 
units of HerculaseII-TopFusion enzyme (Stratagene), 250 µM of each dNTP and 33 
pmol of both S1f and S1r primers. 
 
7. 5. 2 Dot-blot assay 
Dot-Blot technique was used to detect serpin antigens in bacterial cell supernatants 
of B112 and B118 B. longum transformants strains. The protocol was achieved 
with a Bio-Rad Dot-Blot apparatus (Bio-Rad Laboratories, Richmond, CA) 
integrated with a vacuum pump (Millipore Corporation, Bedford, MA), following 
standard procedures (Sambrook et al., 1989). Goat Anti-antitrypsin Polyclonal 
Antibody (Novus Biologicals, Littleton, CO) diluted 1:5000 in Blocking Solution 
and IgG anti-rabbit peroxidase conjugated (Sigma-Aldrich, St.Louis, MO) diluted 
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1:3000 in Blocking solution were used respectively as primary and secondary 
antibodies. A 0.2 µ nitrocellulose membrane (Pierce, Rockford, IL) was used for 
immunochemical reactions with “Supersignal West-Pico Chemiluminescent 
substrate” by BioPierce (Pierce) as substrate solution. TBS (1x) and TTBS (1x) 
solutions were used to wash membranes in several protocol steps. To avoid false 
positive signals, one sample was incubated with the sole secondary antibody. 
Signals were developed and fixed on a Kodak film. 
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Chapter 8: Materials and Methods, section III 
 
8. 1: Probiotic bacteria 
 
Twelve probiotic strains of bacteria were examined. The most of them were 
isolated from commercial cheese (PCA142, PCA185, PCK103, PCS20, PCS22, 
PCS25 and PCS26), two were isolated from Kule naoto that is  a Kenyan Maasai 
milk, obtained from cattle and fermented in cattle’s blood (PCK40 and PCK49), 
one from tanzanian coffee fermentation (PCK87), another was isolated from human 
intestine (PCA244), while PCK66 was isolated from Turkish Salgam that is a 
fermented juice of turnip and carrot. The twelve probiotic strains (tables 8.1 and 
8.2) were previously been tested for their activity against  five different new wide 
spread food-borne pathogens as Saccharomyces cerevisiae, Escherichia coli STEC 
(Shigella toxin-like E. coli), Listeria monocytogenes, campylobacter jejuni and  
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Penicillium nordicum producing ochratoxin, by some partners of Pathogen Combat, 
a project of the 6th Framework Programme of the European Commision, including: 
BFEL (Bundesministerium fur Ernahrung, Landwirtschaft und Verbraucherschutz), 
University of Bologna, Agricultural University of Athens and Danisco A/S. Strains 
were maintained at -80ºC in 20% (v/v) glycerol (Merck, Darmstadt, Germany) and 
were propagated anaerobically in MRS broth (Merck) for 24 h at 37° C using 3 
litres anaerobic jars supplied with CO2 generators (Anaerocult, Merck).  
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PathogenCombat 
Strains 
 
Putative 
Species 
 
Source of 
origin 
 
Antagonistic  
activity 
 
P. nordicum1     S. cerevisiae2     L.. mono.3*     E. coli3     C. jej4              
Pca 142 Lb. fermentum Kasseri cheese + 0 NA NA 0 
Pca 185 Lb. gasseri Feta cheese + 0 NA NA 0 
Pca 244 Lb. reuteri Adult intestine (+) 0 NA NA 0 
Pck 40 Lb. paracasei Kule Naoto + 0 NA NA 0 
Pck 49 Lb. acidophilus Kule Naoto + 0 NA NA 0 
Pck 66 Lb. brevis Ethiopian coffee + 0 NA NA 0 
Pck 87 Lb. plantarum Tanzanian coffee + 0 NA NA 0 
Pck 103 Lb. plantarum Turkish salgam (+) 0 NA NA 1/3 
Pcs 20 Lb. casei Local cheese + 0 NA NA 0/3 
Pcs 22 Lb. plantarum Local cheese + 0 NA NA 0/3 
Pcs 25 Lb. plantarum Local cheese + 0 NA NA 0/3 
Pcs 26 Lb. pentosus Local cheese + 0 NA NA 0/3 
Tab. 8. 1: List of the strains tested, regarding the Working Programme 9 of EU6FP 
PathogenCombat integrated project. All strains were used to evaluate their potential 
probiotic abilities on a porcine small intestine cell model and to use as comparison 
to  B. longum wild type strain and BLSK 7 transformant strain. 1) Tested by BFEL, 
DE. 2) Tested by Danisco S/A, DK. 3) Tested by AUA, GR. 4) Tested by BU, I. *) 
L. mono. stands for L. monocytogenes. C. jej. stands for Campylobacter jejuni 
Symbol references: “+” = strong effect; “(+)”  = weak effect; “0” = no effect; “NA” 
= not assayed (end of 2006); “0/3” = weak effect; “1/3” = average effect.  
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8. 2: Pig  intestinal cell model 
 
8. 2. 1: Epithelial cells 
The intestinal epithelial cell line PSI C1 (Porcine Small Intestine clone 1) (figure 
8.1) and CLAB (figure 8.2) (table 8.2) were grown in advanced Dulbecco’s 
Modified Eagle’s Medium (DMEM) (Sigma-Aldrich, Grand Island, USA), 
supplemented with 5% foetal calf serum (Cambrex, Verviers, Belgium), L-
glutamine (2 mmol/L, Sigma), penicillin (100 units/ml, Sigma) and streptomycin 
(1mg/ml, Fluka, Buchs, CH). Cell lines were routinely grown in 75 cm2 culture 
flasks (Nunc, Roskilde, DK) at 37° C in a humidified atmosphere of 5% CO2 and 
95% air until a confluent monolayer was obtained. Culture medium was changed 
routinely. To obtain polarized monolayers, PSI C1 cells were seeded on 
Transwell® filter inserts (0.4 µm pore size, 12-mm, Corning Incorporated, 
Corning, NY) placed into 12 well plates (diameter: 22.1 mm; Corning 
Incorporated) at a density of 1×105 cells/cm2. A volume of 500 µl cell growth 
medium was added to the inner chamber (apical compartment) and 1500 µl to the 
outer chamber (basolateral compartment). Functional polarity was developed when 
electrical resistance between apical and basolateral surface of the monolayers was 
>3000 Ω/cm2 for PSI C1 cells measured as described below. For experiments 
including PSI C1 cells in the apical compartment and pig blood monocyte cells in 
the basolateral compartment, PSI C1 cells were seeded as described above and once 
polarized were placed into 12 well plates (diameter 22.1 mm; Corning 
Incorporated) containing confluent monolayers of monocytes in the basolateral 
compartment.  
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Fig. 8. 1: PSI c1 porcine small intestine epithelial clone 1 cells in a polarised 
monolayer after 3 days of growth at 37° C  in a humidified atmosphere (5% CO2 / 
95% air) cultured in DMEM in a 25 cm2  flask. Bar stands for 100 µm. 
 
Clab cell line has been tested even in a functional cell model, but without testing its 
electric resistance. Cells were seeded as mentioned above on Transwell filter insert 
(Corning, Inc.) and placed into 12 well plates at a density of  1×105 cells/cm2. A 
volume of 500 µl cell growth medium was added to the inner chamber (apical 
compartment) and 1500 µl to the outer chamber (basolateral compartment).  
Moreover Clab and  PSI c1 cell lines, in regard to all the assays to achieve, were 
previously tested in a single cell system in order to have data to compare. Cells 
were separately seeded in 96 well plates at concentration 1×105  viable cells/ml and 
incubated in a humidified atmosphere of 5% CO2 and 95% air for 24 h at 37° C to 
obtain a confluent monolayer. Before use, monolayers were washed twice with 100 
µl DMEM without phenol red and supplements.  
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Fig. 8. 2: Clab porcine small intestine epithelial cells in a polarised monolayer after 
3  days of growth at 37° C  in a humidified atmosphere (5% CO2 / 95% air) 
cultured in DMEM in a 25 cm2  flask. Bar stands for 100 µm. 
 
8. 2. 2: Monocyte cells 
Monocytes/macrophages from pig blood (PoM2) (Porcine Monocytes clone 2) 
(figure 8.3) were grown in advanced Dulbecco’s Modified Eagle’s Medium 
(DMEM) (Sigma-Aldrich, Grand Island, USA), supplemented with 5% fetal calf 
serum (Cambrex, Verviers, Belgium), L-glutamine (2 mmol/L, Sigma), penicillin 
(100 units/ml, Sigma) and streptomycin (1mg/ml, Fluka, Buchs, Switzerland). Cells 
were routinely grown in 75 cm2 culture flasks (Nunc, Roskilde, Dk) at 37° C in a 
humidified atmosphere of 5% CO2 and 95% air until a confluent monolayer was 
obtained. Culture medium was changed routinely. For experiments including PSI 
C1 cells in the apical compartment and PoM2 cells in the basolateral compartment, 
a confluent monolayer of PoM2 was obtained and cells were seeded on 12 wells 
plates (basolateral compartment) at a density of 1×105 cells/ml and grown as 
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described above. PoM2 cell line has been tested even in a functional cell model, but 
without testing its electric resistance. Cells were seeded as mentioned above on 
Transwell filter insert (Corning, Inc. ) and placed into 12 well plates at a density of  
1×105 cells/cm2. A volume of 500 µl cell growth medium was added to the inner 
chamber (apical compartment) and 1500 µl to the outer chamber (basolateral 
compartment). Moreover,  PoM2 cells were previously tested in regard to all the 
assays to achieve, in a single cell system, in order to have data to compare. Cells 
were separately seeded in 96 well plates at concentration 1×105 viable cells/ml and 
incubated in a humidified atmosphere of 5% CO2 and 95% air for 24 h at 37° C to 
obtain a confluent monolayer. Before use, monolayers were washed twice with 100 
µl DMEM without phenol red and supplements.  
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Fig. 8. 3: PoM 2 porcine blood monocyte cells forming a polarised monolayer after 
3 days of growth at 37° C  in a humidified atmosphere (5% CO2 / 95% air) cultured 
in DMEM in a 25 cm2  flask. Bar stands for 100 µm. 
 
 
 
Fig. 8. 4: Schematic representation of a transwell insert of a twelve well plate 
(Original draw of the author). 
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Bacterial strains and Cell lines Description Source of reference 
Cell lines 
• Clab 
• PoM2 
• PsI c1 
 
Porcine Small intestine Epithelial cells  
Porcine Blood Monocyte cells 
Porcine Small intestine Epithelial cells 
 
Gradijnski and Cencic, 2006 
Gradijnski and Cencic, 2006 
Gradijnski and Cencic, 2006 
Bifidobacterium longum 
• BuSc 112 
• BuSc BSK7 
 
B. longum wild type 
BuSc 112 harbouring pRM3s vector 
 
 
Scardovi V., 1979 
Nissen L., 2007 
Lactobacillus species 
• Pca 142  
• Pca 185  
• Pca 244  
• Pck 40  
• Pck 49  
• Pck 66  
• Pck 87  
• Pck 103  
• Pcs 20  
• Pcs 25  
 
Lb.  fermentum  
Lb. gasseri 
Lb. reuteri 
Lb. paracasei 
Lb. acidophilus 
Lb. brevis 
Lb. plantarum 
Lb. plantarum 
Lb. casei 
Lb. pentosus 
 
PathogenCombat, 2006 
PathogenCombat, 2006 
PathogenCombat, 2006 
PathogenCombat, 2006 
PathogenCombat, 2006 
PathogenCombat, 2006 
PathogenCombat, 2006 
PathogenCombat, 2006 
PathogenCombat, 2006 
PathogenCombat, 2006 
 
Unidentified species 
• Pcs 22 
• Pcs 25 
 
LAB strain isolated from cheese 
LAB strain isolated from cheese 
 
PathogenCombat, 2006 
PathogenCombat, 2006 
 
Control species 
• BFE 403 
• Shirota 
• F19 
• 120021 
 
Carnobacterium divergens 
Lb.  paracasei 
Lb. paracasei 
Lb. reuteri 
 
BFEL, DE.. 
Yakult, J. 
Ljungh Å., 2002 
PathogenCombat, 2006 
Tab. 8. 2: List of bacterial strains and cell lines used in this part of the study to 
evaluate probiotic abilities on a porcine small intestine cell model and to use as 
comparison to B. longum  wild type strain and BLSK 7 transformant strain. 
Bacteria and cells, except B. longum strains, are regarded to the WP9 of EU6FP 
PathogenCombat. 
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8. 2. 3: Cell  count 
To carry out all experiments the number of cells in 1 ml of cell culture were 
counted. In order to achieve the count, 900 µl of 0.1 % trypan blue and 100 µl of 
cell culture were added to a 1.5 ml fresh tube. After cell resuspension, 100 µl of the 
mix were transferred to a hematocytometer and visualised with an inverted light 
microscope at magnification 100 x and cell number was counted in 25 squares, 
applying this formula: 
 
 
Cells / ml of culture = Counted cell number x (106 / 25) 
 
8. 2. 4: Functional polarity 
After that cell cultures have reached a plateau in TER values and the monolayers 
are polarized and established, the functional pig cell models are ready to assay the 
effect of probiotic strains co-cultures. Bacterial strains were resuspended in cell 
growth medium without phenol red and supplements. The bacterial suspension (500 
µl) was added to the apical compartment at a concentration of 1×107 cells/ml and 
incubated at 37° C in a humidified atmosphere of 5% CO2 and 95% air. Cell culture 
medium without addition of bacteria was used as control. The effect of the 
probiotic treatment on cell polarity was evaluated by measurements of the 
transepithelial electrical resistance (TER) using Millicell-ERS Electrical Resistance 
System (Millipore, Bedford,  MA) (Figure 8. 5 and 8. 6).  
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Fig. 8. 5: Picture of a device with its electrode chopstick similar to the Millicell-
ERS Electrical Resistance System (Millipore, Bedford, MA) used in this work to 
measure electric resistances across cell line at the basolateral and at the apical 
compartment of 12 well plate Transwell inserts (Corning, Inc.).  
 
 
Fig. 8. 6: Schematic representation of a transwell well when is used with a 
Millicellers. 
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TER values were measured at different time points during the establishment of 
polarised monolayers (Figure 8. 7) and subsequently during the 72 hours period of 
co-culture with probiotic bacteria. The net value of TER (Ω/cm2) was corrected for 
background resistance by subtracting the contribution of the cell free filter and the 
medium (110 Ω/cm2). TER was measured before the addition of the bacteria (t=0) 
and then at various time intervals. TER of monolayers without bacteria added 
represented the control for each experiment. 
 
  
Fig. 8. 7: Trans Epithelial Electric Resistance of PSI clone1 cells cultured, starting 
from a density of 1×105 cells/cm2, on Transwell® filter inserts (0.4 µm pore size, 
12-mm, Corning Incorporated, Corning, NY) placed into 12 well plate (diameter: 
22.1 mm; Corning Incorporated). Cells were cultured in DMEM at 37° C  in a 
humidified atmosphere (5% CO2 / 95% air).   
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8. 3: Effects of probiotics interaction 
 
8. 3. 1: Adhesion  
Adhesion ability of probiotics was assayed on the three different cell monolayers, 
using a functional cell model. When cells were ready, probiotics were resuspended 
as usually and seeded (1x107 cells/ml) onto monolayers formed in the apical 
compartment and incubated for 90 minutes in humidified atmosphere of 5% CO2 
and 95% air. Then, plates were washed twice in PBS and monolayers were 
trypsinized. Trypsinization was stopped by addition to each insert of 60 µl of  cell 
growth medium without phenol red supplemented with 10% FBS. Cell suspensions 
were transferred and diluted five times, then streaked onto MRS agar Petri dishes 
and incubated up to 72 hours when bacterial colonies became visible. All strains 
assayed have shown to be able to adhere to monolayers, when compared to Lb. 
paracasei F19 as described in chapter 11. 
 
8. 3. 2: Citotoxicity 
Cytotoxic activity exerted by bacteria on cell monolayers after treatment  was 
measured  after 24 hours of  co-incubation of cell monolayers and bacteria (1x107 
bacteria/ ml) at 37° C in atmosphere of 5% CO2. Following incubation, cells were 
carefully rinsed with PBS to remove excess of the bacteria and the plates were 
stained with Crystal violet in ethanol, rinsed with water, and destained with 10% 
(v/v) acetic acid. The absorbance at 595 nm was measured with a microplate reader 
(Multiscan). 
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8. 3. 3: Nitric
 
oxide production  
In 1879, Griess, a German chemist developed a reagent for the detection of nitrite 
in solution (Griess P., 1879). The reagent, an acid solution of sulfanilic acid and 
alpha naphthylamine, undergoes adiazotization reaction with nitrites to form a red 
azo dye. The test was originally intended for assessing bacterial contamination in 
municipal water supplies based on the principle that nitrate present in sewage will 
be reduced to nitrite by the action of bacteria (Shaus and Griess, 1956). Griess first 
described a colorimetric assay to measure the levels of nitrite (NO2-) in aqueous 
solutions over 100 years ago. Modifications to the Griess method have been 
published in more recent years (Green, et al., 1982; Pollock, et al., 1991), a 
fluorometric assay procedure has been published that is 50-100 times as sensitive 
as the Griess colorimetric assay (Figure 8. 8). The bacterial pellet was resuspended 
in cell growth media without phenol red and supplements in indicated 
concentrations and added to washed (2X) confluent monolayers of PSI C1, PoM2 
or CLAB as described above. Monolayers treated with the bacterial suspension 
were incubated for 24 h or 72 h at 37° C in a humidified atmosphere of 5% CO2 
and 95% air. The NO concentration was determined measuring released NO, 
according with the modified Griess reaction (Sigma). Briefly, 50µl supernatant was 
transferred into each well of a 96-well plate and added 50 µl modified Griess 
reagent and incubated 15 min at room temperature. Optical density was measured 
at 540 nm by use of microplate reader (Multiscan).. 
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Fig. 8. 8: Schematic representation of the Modified Griess reaction used to quantify 
nitric oxide cells production with a spectrophotometer set at λ 540 nm. 
 
8. 3. 4: Hydrogen peroxide production 
The bacterial pellet was resuspended in cell growth media without phenol red and 
supplements in indicated concentrations and added to washed (2X) confluent 
monolayers of PSI C1, PoM2 or CLAB as described above. Monolayers treated 
with the bacterial suspension were incubated for 24 h or 48 h at 37°C in a 
humidified atmosphere of 5% CO2 and 95% air. The release of H2O2 was 
determined transferring 50µl of supernatant in a new 96-well plate and by the 
addition of 50 µl 0,01 % peroxidase and 100 µl TMB (Figure 8. 9) solution, diluted 
with distillated water (1:1). After 15 min incubation at room temperature the 
reaction was stopped by addition of 50µl 2mM H3PO4. Optical density was 
measured at 450 nm by use of microplate reader (Multiscan). 
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Fig. 8. 9: Tetramethylbenzidine (TMB) used to quantify H2O2  cells production 
with a spectrophotometer set at λ 452 nm. 
 
8. 3. 5: Extracellular 02- production 
The bacterial pellet was resuspended in cell growth media without phenol red and 
supplements in indicated concentrations and added to washed (2X) confluent 
monolayers of PSI C1, PoM2 or CLAB as described above. Monolayers treated 
with the bacterial suspension were incubated for 24 h or 48 h at 37° C in a 
humidified atmosphere of 5% CO2 and 95% air. The production of extra cellular 
O2- was measured by superoxide inhibitable cytochrome C reduction (Iacobini et 
al., 1997). Briefly, supernatant was transferred into a 96-well plate and added 50 µl 
Cytochrome C solution (80µM) and incubated 1h at room temperature. Optical 
density was measured at 450 nm by use of microplate reader (Multiscan). 
 
8. 3. 6: MTT assay 
Measurement of cell viability and proliferation forms the basis for numerous in 
vitro assays of a cell population’s response to external factors. The reduction of 
tetrazolium salts is now widely accepted as a reliable way to examine cell 
proliferation. The yellow tetrazolium MTT [3-(4,5-dimethylthiazolyl-2)-2,5-
diphenyltetrazolium bromide] is reduced by metabolically active cells (Figure 8. 
10), in part by the action of dehydrogenase enzymes, to generate reducing 
equivalents such as NADH and NADPH. The resulting intracellular purple 
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formazan can be solubilised and quantified by spectrophotometric means. The 
MTT Cell Proliferation Assay measures the cell proliferation rate and conversely, 
when metabolic events lead to apoptosis or necrosis, the reduction in cell viability. 
The number of assay steps has been minimized as much as possible to expedite 
sample processing. The MTT Reagent yields low background absorbance values in 
the absence of cells. For each cell type the linear relationship between cell number 
and signal produced is established, thus allowing an accurate quantification of 
changes in the rate of cell proliferation (Ferrari et al., 1990). The metabolic activity 
of PSI C1, CLAB and PoM2 was measured by the MTT cell proliferation Assay 
(ATCC). The protocol is based on tetrazolium MTT reduction by metabolically 
active cells that result in the intracellular purple formazan, which can be solubilised 
and quantified by a spectrophotometer at 650 nm.  
 
 
Fig. 8. 10: Schematic representation of tetrazolium MTT (3-(4, 5-
dimethylthiazolyl-2)-2, 5-diphenyltetrazolium bromide) reduction used to quantify 
metabolically active cells with a spectrophotometer set at λ 650 nm. 
 
Bacterial pellet was resuspended in cell growth media without phenol red and 
supplements in indicated concentrations and seeded onto washed (2 X) confluent 
monolayers of PSI C1, PoM2 or CLAB. Cell’s monolayers with the added 
probiotic suspension were incubated for 24 h or 48 h at 37° C in a humidified 
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atmosphere of 5% CO2 and 95% air. According to the manufacturer instructions a 
solution of MTT in PBS was added to each well and further incubated for 75 min. 
Solubilization of formazan was achieved after addition of 0.04% HCl in 
isopropanol. The optical density was measured at 650 nm using a microplate reader 
(Multiscan). 
 
8. 3. 7: Immune response 
Dot-Blot techniques were used to detect Interleukin-6 (IL-6) and   Interferon-γ 
(IFN-γ) in PSI C1 and PoM2 cell supernatants grown in a functional cell model 
after probiotic treatment, working with a Bio-Rad Dot-Blot apparatus (Bio-Rad), 
integrated with a vacuum pump (Millipore) and following standard procedures. To 
test a possible cytokine expression in the culture supernatant, primary antibodies 
against polyclonal rabbit anti-pig INF-γ (INRA, Jouy-en-Josas, France) and against 
Interleukin-6 polyclonal rabbit anti-human IL-6 (SIGMA) were used, once diluted 
1:500 in blocking solution. IgG anti-rabbit peroxidase conjugated (SIGMA), 
diluted 1:3000 in Blocking solution, was used as secondary antibody. A 0.2 µ 
Nitrocellulose membrane (Pierce, Rockford, IL) was used for the immuno-chemical 
reaction, while as substrate solution that fix the signals was used the “Supersignal 
West-Pico Chemiluminescent substrate” by Bio Pierce (Pierce). TBS (1x) and 
TTBS (1x) solutions were used to wash membranes in several protocol steps. The 
signals on the membrane to be exposed on a Kodak film were developed and fixed 
with Kodak developer and fixer solutions. Lb. paracasei  F19  was used as positive 
control, while supernatants of monolayers not treated with bacteria were used as 
negative control. To avoid false positive reactions, all samples were even tested 
against the sole secondary antibody anti-rabbit. 
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Part three: Results and Discussions 
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Chapter 9: Results and Discussions, section I 
 
 
9. 1: Adhesion and Autoaggregation 
 
Autoaggregation of bifidobacterial cells and their adhesion to the epithelial mucosa 
are basic processes that get started to the colonization of the intestinal niches. To 
select the ideal strains to investigate the induction of apoptotic deletion of damaged 
cells, we have adapted the screening methods of our previous works (Del Re et al., 
1998; 2000). Among the several strains tested from our culture collection we have 
chosen three strains and defined their adhesion patterns (Table 9.1). B12 strain 
suggests being able of a long term presence in the mucosa due to the abilities to 
adhere to Caco-2 cells and to autoaggregate and can be designated as: “strongly 
adhesive” (Adh+) and “autoaggregating” (Agg+/-). B18 strain suggests an 
intermediate capability of a long term presence in the mucosa and can be 
designated as: “non-adhesive” (Adh-) and “strongly autoaggregating” (Agg+). 
B2990 strain demonstrates to be “non-adhesive” (Adh-) and “non-autoaggregating” 
(Agg-) (Figure 9. 1). The different phenotypes mentioned were significant to 
demonstrate the apoptotic deletion of Caco-2 cells. Indeed, the capabilities of 
Autoaggregation and adhesion are necessary to B. longum to establish a connection 
to the mucosa, to survive through the intestinal bacterial clearance and the 
competition for binding sites and to successfully colonize its niche. 
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Strains of Bifidobacterium 
longum 
 
Adhesion ability 
(%) 
 
Autoaggregation 
ability (%) 
 
Pattern 
description 
 
B.  longum BuSc B12 
 
68 ±  0.21 
 
55 ± 0.26 
 
Adh+ and Agg+/- 
 
B. longum BuSc B18 
 
3  ± 0.11 
 
75 ± 0.17 
 
Adh- and Agg+ 
 
B. longum BuSc B2990 
 
2 ± 0.2 
 
4 ± 0.22 
 
Adh- and Agg- 
Table 9. 1: Strains description and abilities. Adh+) strongly adhesive. Adh-) non 
adhesive. Agg+) strongly autoaggregating. Agg-) non autoaggregating. Agg+/-) 
autoaggregating. Adhesion is expressed as mean ± S.E. of bifidobacterial adhering 
cells x 100 Caco-2 cells. Autoaggregation is expressed as mean ± S.E. as 1 - (O.D. 
upper suspension / O.D. total bacterial suspension) x 100. Results are 
representative of three independent experiments following the previous methods 
introduced by Del Re B. et al 2000. 
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Figure. 9. 1: Co-cultures of  Gram stained Bifidobacteria and Caco-2 cell line 
photographed under light microscope, visualised at 1000x magnification. Pictures 
were taken after a single wash in PBS to remove non adherent bacteria. A) 
Bifidobacterium longum B2990 strain adhering on Caco-2 cells monolayer. B) B. 
longum B18 strain adhering on Caco-2 cells monolayer. C) B. longum B12 strain 
adhering on Caco-2 cells monolayer. Bar indicates 1 mm. 
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9. 2: Apoptosis detection  
 
Caco-2 cells were grown until differentiation and not unless the 80% of confluence 
was reached. Bifidobacterial strains were taken in their exponential phase of 
growth to achieve the test. After three hours of incubation of bacteria with Caco-2 
cells, we isolated eukaryotic DNA and performed a DNA ladder assay (Figure 9. 
2). The DNA samples from Caco-2, incubated with B12 and B18 B. longum strains 
as co-cultures, have undergone fragmentation. These two strains were designated as 
adherent and capable of a long term presence in the colon mucosa. The DNA 
sample from Caco-2, which did not show fragmentation, was the one treated with 
the B2990 strain known as Adh- / Agg-, capable of very weak adhesion and 
autoaggregation. 
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Fig. 9. 2: DNA ladder results. Ethidium bromide stained TBE 1% agarose gel. Lane 
1) Caco-2 cells treated with campothecin used as positive control. Lane 2) Caco-2 
cells induced by Bifidobacterium  longum  B12 showing DNA fragmentation.  Lane 
3) Caco-2 cells, induced by B. longum B18 shows DNA fragmentation. Lane 4) 
Caco-2 cells induced by B. Longum B2990 showing a DNA smear and no DNA 
fragmentation. Lane 5) Caco-2 cells incubated with PBS only, used as negative 
control. Results are representative of three independent experiments.  
 
 
9. 3: Discussion 
In this preliminary investigation we have observed a relationship between the 
adhesion properties of the B. longum strains and the ability to induce apoptotic 
deletion of the human enterocyte-like Caco-2 cell line. Our observations confirms 
precedent hypothesis, made isolating a 160 kDa cell wall associated protein from 
one of the most adherent B. longum strain of our collection. This protein could be 
involved in adhesion mechanisms (Ferrarini et al., 2003) and have homologies 
(data not shown) with eukaryotic serpins (serine proteases inhibitors). It is known 
that probiotics and in particular bifidobacteria exert direct activity on the colon 
 106
epithelia, regulating the tissue homeostasis. Indeed, it is reported that the 
commensal microflora can stimulate regeneration, differentiation and proliferation 
of the colon tissue. Our results could be somehow due to inducers of apoptosis such 
as proteins of the serpin superfamily. Indeed, in the full genome sequence of B. 
longum is reported an eukaryotic type serpin (Schell et al., 2002), which has 
recently been characterized (Ivanov et al., 2006) In eukaryotes, serpins controls key 
steps in physiological regulatory cascades, such as inflammation and apoptosis, by 
inhibiting specific proteases (Silvermann et al., 2001). In some cases, serpins plays 
important roles in immune system evasion during pathogenesis (Macen et al., 
1993). Colonization is the only way how prokaryotes can interact with eukaryotic 
plasma membrane and establish a communication between. With a long lasting 
interaction, Bifidobacteria could module the human immune system or take part in 
cellular homeostasis, restoring the ecology of a damaged GIT tissue as the 
apoptotic deletion of Caco-2 cells suggests. 
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Chapter 10: Results and Discussions, section II 
 
 
10. 1: DNA Manipulation 
 
10. 1. 1: Sib selection screening 
The gene of interest was screened in the library of B. longum genome via a non 
radioactive protocol, using 0.5 units of HerculaseII-TopFusion enzyme 
(Stratagene), 250 µM of each dNTP and 34 pmol of both S1f and M13uni primers 
(Table 1). The PCR profile was as follow: 96°C for 2 min followed by 30 cycles 
(each cycle: 95 °C for 20 s, 53 °C for 20 s, 72 °C for 30 s) and a final extension at 
72 °C for 3 min. After three rounds of screening the positive clones were picked 
and assayed (Figure 10. 1). 
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Fig. 10. 1: PCR electrophoretogram of non-radioactive library screening via a sib-
selection protocol, using Herculase II enzyme. 1) and 16-18) plaques negative to 
serpin gene internal fragment. 2-9) and 11-15) plaques positive to serpin gene 
internal fragment. 10) DNA Ladder 20 Kb. 
 
10. 1. 2: Vector construction 
Plasmids rescue and oligonucleotides purification permitted to construct the vector 
for E.coli and B. longum transformations. Manipulated inserts and original inserts 
were firstly charge for an electrophoretic run on a 1.8 % low melting agarose gel 
and than  quantify and purity checked with a UVis spectrophotometer The the 0.9 
Kb insert fragment was manipulated to introduce BamHI sticky fingers and to be 
cloned in pRM2 and in pUC18, generating respectively pRM3 () and pUC18Serpin 
(Figures 10. 2  and 10. 3). 
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Fig. 10. 2: Construction of pRM3. The first recombinant plasmid was constructed 
as previously described (Missich et al., 1994). The construction of pRM3 was 
concluded digesting plasmid and serpin insert and ligating both product with T4 
DNA Ligase. Restriction sites and enzymes used are shown in the picture. 
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Fig. 10. 3: Insert check. 1) Gene Ruler DNA Ladder Mix (Fermentas). 2, 3 and 4) 
S1r/M13uni fragment (0,9Kb). 5, 6 and 7) XbaI-S1r/M13 fragment (0,9Kb), both at 
different dilutions.  
 
 
10. 2: Transformation 
 
10. 2. 1: Escherichia coli  
E. coli XL1 strain was made competent and chemically transformed with both new 
plasmids. XL1 transformants were selected for ampicillin and α-complementation 
assay and finally with PCR using 1 unit of Pfu DNA Polymerase (Fermentas), 250 
µM of each dNTP and 34 pmol for both S1f and M13uni primers (Table 1). The 
PCR profile was as follow: 96 °C for 1 min followed by 30 cycles (each cycle: 95 
°C for 30 s, 53 °C for 30 s, 72 °C for 2 min ) and a final extension at 72 °C for 3 
min (Figures 10. 4).  
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Fig. 10. 4: Pfu PCR electrophoretogram of E. coli screening  with and S1r/M13uni 
primers pair. 3, 4, 5, 6, 8 and 9) Positive E. coli transformants colonies screened via 
PCR. Seeking for 0,9 Kb fragment.  7) Gene Ruler DNA Ladder Mix (Fermentas). 
 
10. 2. 2: Bifidobacterium longum 
Two clones were chosen, pRM3 and pUC18Serpin were purified, while B. longum 
B12 and B18 strain were made competent to be electro-transformed with both 
plasmids using a Gene-Pulser apparatus (BioRad Laboratories, Ca) . Several 
protocols for B. longum transformation were performed to obtain best efficiency. 
The best one tested was the one made with MRS medium and raffinose, which led 
to 3.3 x 104 transformants/µg DNA (Table 10. 1). Transformants were finally 
screened for ampicillin, for spectinomycin and for α-complementation and via a 
colony PCR with Pfu DNA polymerase.  
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Strains transformed 
 
Sugar supplement 
to MRS medium 
 
Transformation efficiency 
(transformants/µg DNA) 
 
Bifidobacterium longum B112 
+ pRM2 S1f/M13 insert  
 
 
 
 
 
Bifidobacterium longum B118 
+ pRM2 S1f/M13 insert  
 
 
 
Glucose 0.7 mol/l 
Lactose 0.5 mol/l 
Ribose 0.5 mol/l 
Raffinose 0.8 mol/l 
 
 
 
Glucose 0.7 mol/l 
Lactose 0.5 mol/l 
Ribose 0.5 mol/l 
Raffinose 0.8 mol/l 
 
1.2 x103 
2.2 x 103 
1.1 x 102 
2.7 x104 
 
 
 
1 x103 
2.3 x103 
5.6 x101 
3.3 x104 
Tab. 10. 1: Transformation efficiency in Bifidobacterium longum B112 and B118 
with pRM3 using different sugars (NaMR buffer, 12.5 kV/cm, 100/200 Ω and 25 
µF).  Results are from at least three independent experiments. 
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10. 3: Serpin detection 
 
10. 3. 1: PCR analysis 
To confirm biochemical screening of B. longum B112 and B118 transformants, a 
colony PCR was performed using 1 unit of Pfu DNA Polymerase (Fermentas), 250 
µM of each dNTP and 34 pmol for both S1f and M13uni primers (Table 1). The 
PCR profile was as follow: 96 °C for 7 min followed by 30 cycles (each cycle: 95 
°C for 30 s, 53 °C for 30 s, 72 °C for 2 min ) and a final extension at 72 °C for 3 
min (Figure 10.5).  
 
 
Fig. 10. 5: Pfu PCR electrophoretogram of B. longum transformants seeking for 0,9 
Kb fragment. 3, 4, 5, 9, 11 and 12) Putatively positive B. longum transformants 
colonies screened via PCR with S1r/M13uni primers pair.. 7) Gene Ruler DNA 
Ladder Mix (Fermentas) 
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In order to confirm the integrity of cloned Serpin gene in pRM3 from positive 
transformants B. longum, 10 ng of rescued pRM3 were used as template in a PCR 
reaction with 0.5 units of HerculaseII-TopFusion enzyme (Stratagene), 250 µM of 
each dNTP and 33 pmol of both S1f and S1r primers. The PCR profile was as 
follow: 98 °C for 1 min followed by 26 cycles (each cycle: 95 °C for 20 s, 55 °C 
for 20 s and 72 °C for 20 s) and a final extension at 72 °C for 2 min. All PCR 
protocols were performed in a 25 µl reaction with a Biometra T-Gradient 
thermocycler (Biometra GmbH, Goettingen, Germany) (Figure 10. 6). 
 
 
 
Fig. 10. 6: PCR electrophoretogram of pRM3 prepared from transformants B. 
longum strains. Amplification of serpin encoding gene S1f/S1r internal fragment, 
using pRM3 as template DNA. M: Gene Ruler DNA Ladder Mix (Fermentas); lane 
1: pRM3; lane2: S1f/S1r amplicons from B112 transformant strain; lane3: S1f/S1r 
amplicons from B118 transformant strain; lane 4: negative control. 
 
 
 
 115
10. 3. 2: Dot-blot assay 
Supernatants of B112 and B118 B. longum strains and B12 wild type strain were 
used in a dot-blot assay to detect presence of antigens to goat anti-antitrypsin 
polyclonal antibody. Signal comparison with positive antitrypsin control shows that 
both B. longum B112 and B118 produce a signal twice stronger than B. longum 
B12 wild type strain, confirming the expression of cloned serpin encoding gene 
(Figure 10. 7). 
 
 
 
Fig. 10. 7: Dot Blot assay against goat anti-antitrypsin in bacterial cells supernatant 
of transformants Bifidobacterium longum B112, B118 and B12 B. longum wild-
type. Row A, lane 1: B. longum B12 wild type strain; lane 2: B. longum B112 
(harbouring pRM3); lane 3) B. longum B118 (harbouring pRM3). Row B, lane 1: 
control with the sole secondary antibody; lane 2) negative control (no supernatant); 
lane 3) positive control anti-antitrypsin. 
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10. 5: Discussion 
 
Aim of this work was to clone a surface protein encoding gene, showing high 
homologies with the serpin encoding gene of B. longum (Ivanov et al., 2006) and 
presenting the highly conserved domain of serine inhibitors. The presence of a 
specific serpin gene in B. longum genome had recently passionate several scientists, 
because until this issue prokaryotic serpin genes were present just in pathogen 
bacteria and used to take role in their pathogenesis, especially during inflammation 
stages. Otherwise is well known the probiotic nature of B. longum that in its 
symbiosis with the gut never originates any kind of damage to the host, but 
contributes to the body well being, even strengthening the host immune system. 
The course to know which is the serpin role in   B. longum gut symbiosis is open 
and we focused our study on some strains that are capable of a strong adhesion to 
Caco-2 cell monolayer and high co-aggregation level, which are profiles of their 
host colonisation capability. Moreover these bacterial strains used to express high 
amount of the original surface protein, now compared with the serpin gene. The B. 
longum strains chosen for electro-transformation are able to induce apoptosis in 
damaged cells; in facts, we had previously tested their induction of apoptotic 
deletion of adenocarcinoma Caco-2 cell line (Nissen et al., 2006). After the 
screening of B. longum DNA library in lambda phages, the excision of positive 
phages and the isolation and clean up of  the appropriate fragment, our gene was 
subcloned in pRM2, a RCR plasmid, that act as an E. coli - B. longum shuttle 
vector (Missich et al., 1994), to give pRM3. Unfortunately, the electroporation 
efficiency in   B. longum always used to be very low and so had to be improved. 
Bifidobacterium species are difficult to transform by known techniques. These 
microorganisms are called recalcitrant (Guglielmetti et al., 2007). Transformation 
is strenuous and the genetic material needs to be highly pure. Until now the highest 
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level of transformation in B. longum was obtained with a shuttle vector of 
pBLES100 series that produces 1.6 x 104 transformants/µg DNA (Nakamura et al., 
2002). In previous works the best efficiency of transformation obtained with the 
pMB1 replicon-based plasmid series was lower than 1 x 103 transformants/µg DNA 
(Missich et al., 1994). To achieve better results, different electroporation protocols 
were performed leading to the maximum efficiency with 3.3 x 104 transformants/µg 
DNA. The clones obtained were stored lyophilised in several replicates. These 
bacteria will be used to test apoptotic induction in normal intestinal epithelial cells 
and blood monocytes and in tumor intestinal cell lines in the way to monitor and 
better understand serpin role in the elimination of bad cells and in restoring 
damaged ecology. 
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Chapter 11 Results and Discussion, section III 
 
 
11. 1: Adhesion and Cytotoxicity 
 
11. 1. 1: Adhesion to epithelial cells 
Almost all bacteria tested have shown to have adhesive properties to PSI C1 
intestinal epithelial cell line, even the strains that exhibit a weaker effect, still 
remain in part adhered to epithelial monolayers. In fact, when these bacteria are co-
cultured with PSI c1 for 90 minutes at 37° C in a humidified atmosphere of 5% 
CO2 and 95% air using DMEM without Phenol red, FBS and antibiotics, show to 
resist to cell line medium and micro-ecosystem in a percentage referred to the 
initial concentration of the inoculum. The range of  % of adhesion is between 73 % 
of Pck 87 and 39 % of Pck 66; so even Pck  66, that have a weak effect, still remain 
in part attached to epithelial surface (Table 11. 1) 
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Strains 
  Adhesion %  
after 90 minutes 
 
Description 
 
Bifidobacterium longum 
• BuSc 112 
• BuSc BSK7 
 
 
59 ± 0.26 
53 ± 0.17 
 
 
 Adh + 
 Adh + 
 
Lactobacillus species 
• Pca 142  
• Pca 185  
• Pca 244  
• Pck 40  
• Pck 49  
• Pck 66  
• Pck 87  
• Pck 103  
• Pcs 20  
• Pcs 25  
 
 
49 ± 0.15 
41 ± 0.23 
63 ± 0.11 
65 ± 0.17 
41 ± 0.11 
39 ± 0.09 
73 ± 0.25 
66 ± 0.10 
55 ± 0.13 
49 ± 0.18 
 
 
Adh 
 Adh  
    Adh + 
       Adh ++ 
 Adh  
 Adh  
       Adh ++ 
       Adh ++ 
    Adh + 
                             Adh  
 
 
Unidentified species 
• Pcs 22 
• Pcs 26 
 
 
 
65  ± 0.21 
69 ± 0.16 
 
 
 
Adh + 
Adh + 
 
Tab. 11.1:  Strains adhesion abilities on PSI c1. Adh++) strong adhesive. Adh+) 
adhesive Adh) weak adhesive. Adhesion was expressed by the mean ratio (%, ± 
S.E.) of the concentration in the  inoculum to the that in the suspension after 90 
minutes of co-culture with PSI c1 epithelial cell line. Bacterial cells after this time 
were washed, resuspended at several dilutions and streaked on MRS agar plate, 
then incubated routinely up to 72 hours to determine CFU/ml. Results are 
representative of three independent experiments.  
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11. 1. 2: MTT assay 
The metabolic activity of PoM2, PSI C1 and CLAB was investigated after co-
culturing with probiotic strains. Lb. casei Shirota and Carnobacterium divergens 
BFE403 were used as positive and negative control, respectively, while cell lines 
without added bacteria were used as control well. Absorbance values that are lower 
than the control cells indicate a reduction in the rate of cell proliferation. 
Conversely a higher absorbance rate indicates an increase in cell 
proliferation.When PSI C1 and CLAB were grown independently in single cell 
systems using 96-well plates the metabolic activity of both cell lines increased 
slightly after exposure to 1×106 bacteria/ml. Instead, when the co-culture with 
probiotics is made testing PoM2 in the same conditions, a loss in metabolic activity 
is detected (figure 11. 1). But, when PoM2 are cultured coupled with PSI C1 in 12 
Transwell plate, there is no loss in monocytes metabolic activity, because PoM2 are 
not directly in contact with bacterial cells (figure 11. 2). This result can be related 
to what happen in vivo, where monocytes rarely come in strict contact with 
commensal probiotic bacteria. No significant difference was observed in between 
the probiotics strains, but in comparison with Lb. paracasei Shirota, Pck 66, Pck 87 
and in minority, Pcs 20 can lead cells to a reduction in metabolic activity. Anyway 
in comparison with the control well with no bacteria added, there are little 
differences in both increase and loss of metabolic activity, thus in any cases there 
are no changes in normal metabolic activity of cell lines, even considering that 
rarely an increase in proliferation may be offset by cell death. This result confirms 
that the bacteria tested are not harmful for the cell lines used for the assay. 
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Fig. 11. 1: MTT Proliferation assay of different cell lines cultured in 96 well plates, 
after 24 hours exposure to probiotic bacteria. Yellow tetrazolium MTT was added 
at  each well and incubated for 75 minutes. reaction was achieved with 0.04 % HCl 
in isopropanol. The optical density was measured with a multiplate reader set at 
650 nm. Absorbance values that are lower than the control cells indicate a 
reduction in the rate of cell proliferation. Conversely a higher absorbance rate 
indicates an increase in cell proliferation. ±S.E <0.05. Three replicates were 
performed 
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Fig. 11. 2: MTT Proliferation assay of PSI C1 and PoM2 coupled cultured in12 
Transwell plates, after 24 hours exposure to probiotic bacteria. Yellow tetrazolium 
MTT was added at  each well and incubated for 75 minutes. reaction was achieved 
with 0.04 % HCl in isopropanol. The optical density was measured with a 
multiplate reader set at 650 nm. Absorbance values that are lower than the control 
cells indicate a reduction in the rate of cell proliferation. Conversely a higher 
absorbance rate indicates an increase in cell proliferation. ±S.E <0.05. Three 
replicates were performed. 
 
11. 1. 3: Cytotoxicity 
Cytotoxicity of  bacterial supernatants on PoM2, PSI C1 and CLAB monolayers 
was investigated after 24h co-culturing cells with the probiotic strains. A sole 
control of monolayers with no bacteria tratment was used as control. Absorbance 
was measured at 450 nm, and the results were expressed by the mean ratios 
(%, ± SD) of absorbances in treated wells to those in control wells All results are 
compared with this control and, as shown in figure , there are no significant 
citotoxic activity exerted by probiotics on epithelial cell lines (PSI C1 and CLAB). 
For these two cell lines the reduction in viability rarely overcomes the value of 10 
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% and in that cases are included the assays made with Pck 49, Pck 66 and Pck 87. 
Thus, this result indicates that the three last mentioned bacterial strains are the most 
aggressive, when compared to the others of the list and can generate a slight stress 
condition for cell lines. Otherwise, when pig blood monocytes (PoM 2) are exposed 
to a concentration at 107 bacterial cells/ml for 24 hours in routine incubation 
conditions, there is a loss of viability in monocyte cells, in fact absorbance 
measured at 595 nm is slightly higher compared to that of epithelial cell lines, 
meaning that bacterial co-cultures stress monocyte cells. These results are arguable 
considering that in vivo there are few possibilities of a contact between known 
probiotic bacteria and blood monocyte cells (Figure 11. 3).  
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Fig. 11. 3: Citotoxicity effect of probiotic bacterial exposure to the different cell 
lines expressed as viability reduction in %. Cells were cultured, seeded at 6 x 106 
cells/well, in single cell systems using 96 well plates and, when monolayers got 
confluent, were exposed to 1x107 bacteria/ ml, then co-coltured for 24 hours at 37° 
C in atmosphere of 5% CO2. Cells were stained with crystal violet and destained 
with acetic acid 10% (w/v) and the optical density measured with a 
spectrophotometer set  at 595 nm. Three replicates were performed and the results 
were expressed by the mean ratios (%, ± SD) of absorbances in treated wells to 
those in control wells 
 
11. 2: ROS and Nitric Oxide production 
 
11. 2. 1: Hydrogen peroxide production 
The assays needed to measure hydrogen peroxide release by cell lines after 
exposure to the examined probiotic strains at 1 x 107 bacteria/ml, was conducted 
both in a single cell system, using 96 well plates, and in a double cell system, using 
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12 Transwell plate. Lb. reuteri  and Car.  divergens were taken as positive and 
negative control, respectively. Three replicates were performed. Absorbance at 450 
nm was measured, and the results were expressed by the mean ratios (%, ± SD) of 
absorbances in treated wells to those in control wells. As seen in figures 11.4 and 
11.5 no significant production of hydrogen peroxide was detected in both the 
systems tested; thus, just strains Pck 49, Pck 66 and Pck 87 shows to induce cell 
lines to produce more than the 10 % of amount of hydrogen peroxide, when this is 
related to the control well, where cells are not exposed to probiotics. Anyway, even 
Pck 87 results seems in contrast, since the activity shown in the assay with the 
double cell system lowers in the assay with single cell system. These results could 
be due to the original source of habitat of these strains that are found associated to 
process of strict fermentation in topic and changing ecosystems, as coffee 
fermentation and in Kule Naoto fermented milk.  Moreover, BuSc B12 and BLSK 
7 do not manifest to induce cell lines to produce antagonistic hydrogen peroxide, as 
demonstrate the results, included between 4 and 10 % of hydrogen peroxide 
release, that are so close related to that of the average of all tested bacteria.  In 
conclusion, it can be stated that these bacterial strains do not induce cell lines to 
produce relevant amounts of hydrogen peroxide, thus not reaching a toxic level, but 
remaining at that level of hydrogen peroxide that is known to be beneficial for host 
eukaryotic cells, contributing to a good cell tenor.  
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Fig. 11. 4: Effect of tested bacterial strains on H2O2 release by the different cell 
lines cultured independently in a single cell system for 24 hours. Cell were seeded 
in a 96 well plate at 1 x 105 cells/ml and then exposed to 1 x 106 cells/ml of 
probiotic culture and incubated at 37° C in atmosphere of 5% CO2. Then, the 
amount of released H2O2 in cell supernatant was measured by addition of 
peroxidase and TMB solution. Reaction was stopped with H3PO4 as described 
under chapter 8. Three replicates were performed. Absorbance at 450 nm was 
measured, and the results were expressed by the mean ratios (%, ± SD) of 
absorbance in treated wells to that in control wells. 
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Fig. 11. 5: Effect of tested bacterial strains on H2O2 release by PSI C1 and PoM2 
cultured in a double cell system for 24 and 48 hours. Cells were seeded in a 12 
Transwell plate at 1 x 105 cell/ml density in both compartment and then exposed to 
1 x 106 cells/ml of probiotic culture and incubated at 37° C in atmosphere of 5% 
CO2. Then, the amount of released H2O2 in cell supernatant was measured by 
addition of peroxidase and TMB solution. Reaction was stopped with H3PO4 as 
described under chapter 8. Three replicates were performed. Absorbance at 450 nm 
was measured, and the results were expressed, by the mean ratios (%, ± SD) of 
absorbances in treated wells to those in control wells. 
 
11. 2. 2: Extracellular superoxide production 
The production of extra cellular O2- was measured by superoxide inhibitable 
cytochrome C reduction (Iacobini et al., 1997). Briefly, supernatants were used to 
react with 80µM Cytochrome C solution and were incubated 1h at room 
temperature. Optical density was measured at 450 nm by use of microplate reader 
(Multiscan). Lb. paracasei F19  and Car.  divergens were taken as positive and 
negative control, respectively. Three replicates were performed. Absorbance at 550 
nm was measured, and the results were expressed by the mean ratios (%, ± SD) of 
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absorbancies in treated wells to those in control wells.  The assay permit to evaluate 
the activation of PoM2 monocytes after exposure to the examined probiotic strains 
at a concentration of 1x106 cells/ml, compared to monocytes without bacteria 
added, as control well. The production of extracellular superoxide was measured in 
PoM2 cultured coupled with PSI C1 in 12 Transwell plates or in a single cell 
system using 96 well plates. Furthermore, superoxide production was tested even 
on PSI C1 and Clab epithelial cell lines in a single cell systems using 96 well plates 
to compare the signals. As seen in figure 11.6, no significant production of 
extracellular superoxide was observed when compared to monolayers not co-
cultured with bacteria, in any of the culturing methods used. 
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Fig. 11. 6: Superoxide production exerted by PSI C1 and PoM2 cultured in a 
double cell system for 24 and 48 hours, after exposure to probiotic bacteria. Cells 
were seeded in a 12 Transwell plate at 1 x 105 cell/ml density in both compartment 
and then exposed to 1 x 106 cells/ml of probiotic culture and incubated at 37° C in 
atmosphere of 5% CO2. Three replicates were performed. Absorbance at 550 nm 
was measured, and the results were expressed by the mean ratios (%, ± SD) of 
absorbances in treated wells to those in control wells. 
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11. 2. 3: Nitric oxide production 
The effect of nitric oxide production by cell lines after exposure to the examined 
probiotic strains at 1 x 106 bacteria/ml, was conducted both in a single cell system, 
using 96 well plates, and in a double cell system, using 12 Transwell plate. Lb. 
paracasei F19  and Car.  divergens were taken as positive and negative control, 
respectively. Three replicates were performed. Absorbance at 540 nm was 
measured, and the results were expressed by the mean ratios (%, ± SD) of 
absorbances in treated wells to those in control wells. As seen in figure 11.7 and in 
figure 11.8 no significant production of NO was observed when compared to 
control wells in both single cell system and double cell model. In particular the 
accumulation of nitric oxide was very low when the bacterial strains were tested on 
PoM2, in comparison to the accumulation of nitric oxide in control well and 
compared to the values of tested epithelial cell lines. This result is in line with the 
natural deficiency of nitric oxide production by monocytes, that uses to accumulate 
this molecule in very low amount or when is strongly induced or stressed. Even in 
the double cell model including PSI C1 in the apical compartment and PoM2 in the 
basolateral compartment, there are evident differences between the two culture 
compartments. Epithelial cells can produce nitric oxide in response to stress factors, 
but even to improve cell tenor and to stimulate cell proliferation. The first type of 
accumulation is done at high nitric oxide concentration, while the second type is 
related to a low nitric oxide concentration, that is in line with the results obtained 
for this test. Omitting the results obtained with PoM2 monocytes,  due to cell 
natural behave, and thus, considering the effect of bacterial strains on nitric oxide 
accumulation  just in PSI C1 and Clab epithelial cells, there are no significant 
difference was observed in between the probiotics strains. In comparison with Lb. 
paracasei F19, Pck 66, Pck 87 and Pcs 26 can lead cells to an slightly higher nitric 
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oxide production in the range of the 10%. Anyway in comparison with the control 
well with no bacteria added, there are little differences that are all included in a 
range that never overcome the value of  0,4 mMol of nitric oxide concentration. 
This result confirms that the bacteria tested are not harmful for the cell lines used in 
the assay, but could be beneficial, contributing cells to produce a non toxic level of 
nitric oxide . 
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ig. 11. 7: Effect of tested bacterial strains on Nitric oxide 
 
accumulation by all cell 
lines cultured independently in 96 well plates. Once monolayer were confluent, cell 
lines were exposed for 24 to 1 x 106 bacteria / ml at 37° C in atmosphere of 5% 
CO2. Following incubation, realised NO in cell supernatant was measured by 
addition of Griess reagent as described under chapter 8. Absorbance values were 
measured  with a multiplate reader at 550 nm and mMols of nitric oxide 
accumulation were extrapolated using a standard curve made with sodium nitrate. 
The results were expressed by the mean ratios (%, ± SD) of absorbances in treated 
wells to those in control wells 
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Fig. 11. 8: Effect of tested bacterial strains on Nitric oxide 
 
accumulation by PSI c1 
and PoM2 cell lines cultured coupled in 12 Transwell plates. Once monolayer were 
polarised, cell lines were exposed for 24 and 48 hours to 1 x 106 bacteria/ ml at 37° 
C in atmosphere of 5% CO2. Following incubation, realised NO in cell supernatant 
was measured by addition of Griess reagent as described under chapter 8. 
Absorbance values were measured  with a multiplate reader at 550 nm and mMols 
of nitric oxide accumulation were extrapolated using a standard curve made with 
sodium nitrate.The results were expressed by the mean ratios (%, ± SD) of 
absorbances in treated wells to those in control wells.  
 
11. 3: Transepithelial Electric Resistance 
As shown in Figure 11.9, the  probiotic strains examined, used at a concentration of 
1x107 bacteria/ml, increased TER of polarized monolayers of PSI C1 from 
approximately 4000 ohm to >6000 ohm, but after 48 hours of co-culture TER starts 
dramatically decreasing to control value, maybe due to bacterial starvation and 
death that affect monolayers structure. No significant difference was observed 
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between the strains. The TER of PSI C1 monolayers with no bacteria added were 
constant (~3000 Ω) within 72 h. This means that the increase in TER generated by 
cells co-cultured with bacteria can maintain a low permeability of the epithelium to 
passive ion flux and avoid the deterioration of its barrier function not just against 
pathogens.  
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Fig. 11. 9: Transepithelial electrical resistance (TER) of polarised PSI C1 cell lines 
seeded at 1 x 106  in 12 Transwell plates grew until monolayers polarization and 
then exposed in co-cultures to 1×107 bacteria/ml. A sole control with no bacteria 
added was used as control well. ±S.E <0.05. Three replicates were performed.  
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11. 4: Immune Response 
 
Dot-Blot was achieved against antibodies IFN-γ and IL-6 to detect the presence of 
specific antigens in culture supernatant after 24 and 48 hours exposure to bacteria. 
PoM2 and PSI C1 were tested alone or in combination, having PSI C1 in the apical 
compartment and PoM2 in the basolateral. PSI C1 alone was tested against IL-6, 
while PoM2 with PSI C1 was assayed against IFN-γ. As figure 11.10 shows, the 
best reactions obtained are that ones of cells treated for 48 hours. Interleukin-6 
detection is more clear than IFN-γ detection; this could be due to the long lasting 
interaction of bacteria and cells of the 48 h treatment compared to the 24 h 
treatment. It can be supposed that after 24 hours the immune response is still 
unstable and not so specific, even because some positive signals disappear in the 48 
hours treatment. Anyway, almost all the samples have shown reactivity against IL-
6 antibody; this issue is easy to understand and confirm the well-known 
immunostimulating abilities of probiotics. In fact, while interferon-γ is a cytokine 
secreted by animal cells to challenge pathogens and tumours, Interleukin-6 is a pro-
inflammatory cytokine secreted by animal cells to stimulate immune response to 
several traumas.  
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Fig. 11. 10: Dot-Blot experiments for the detection of antigens in culture 
supernatants for IL-6 antibody in PSI C1 and for IFN-γ  antibody in PoM2. Three 
replicates were performed. Each row corresponds to each bacterial strain used in 
the treatment, as follow: row 1) PCA142, row 2) PCA185, row 3) PCA244, row 4) 
PCK40, row 5) PCK49, row 6) PCK66, row 7) PCK87, row 8) PCK103, row 9) 
PCS20, row 10) PCS22, row 11) PCS25, row 12) PCS26. Il-6 detection. Line A) 24 
h PSI C1 apical compartment. Line B) 24 h PSI C1 basolateral compartment. Line 
D) 48 h PSI C1 apical compartment. Line E) PSI C1 48 h basolateral compartment. 
IFN-γ detection. Line F) 24 h PSI C1/PoM2 apical compartment. Line G) 24h PSI 
C1/PoM2 basolateral compartment. Line H) 48 h PSI C1/PoM2 apical 
compartment. Line I) 48 h PSI C1/PoM2 apical compartment. Controls are located 
in line C, row 3 and 4, Il-6 and IFN-γ, respectively. Controls in line J, rows 1, 2, 3 
and 4 are respectively:  J1) Il-6 detection: 24 h PSI C1 not treated, J2) Il-6 
detection: 48h PSI C1 not treated, J3) IFN-γ detection: 24 h PoM2 not treated, J4) 
IFN-γ detection: 48 h PoM2 not treated. 
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11. 5: Discussion 
 
The metabolic activity of PoM2, PSI C1 and CLAB increased slightly after direct 
exposure to a concentration of 1 × 107 bacteria/ml of any of the twelve probiotic 
strains tested and do not affect mitochondrial functions. Probiotic treatments 
manifested no cytotoxicity over PSI C1, CLAB and Pom2 monolayers, when 
compared to free-bacteria monolayers. In addition 1×107 bacteria/ml increased the 
transepithelial electrical resistance of polarized monolayers of PSI C1 and thereby 
strengthened the epithelial barrier function (Figure 11.11). These results indicate 
that the examined probiotics are not harmful when exposed to an healthy intestine. 
Furthermore, no cell activation was observed  after exposure probiotics as 
measured by the release of NO, H202 and O2- with PoM2, CLAB or PSI C1 
monolayers grown in plastic or with  PoM2 and PSI C1 grown in a functional cell 
model, even if  three strains of the PCS series showed in both culturing system an 
high H2O2 production. Anyway, as seen in the TER experyment, seems that 
probiotics bacteria can last no longer than 72 hours when are co-cultured with cells 
in a functional cell model. This could be due to starvation when bacteria are firstly 
seeded at concentration of 1 x 107 bacteria/ml. Examinations of the 
immunostimulating effect of probiotics on PSI C1and PoM2 showed that almost all 
strains induce cells to secrete Il-6. 
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Fig. 11. 11. Schematic representation of TER applications (Original draw of the 
author). 
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Chapter 12: Conclusions 
 
In conclusion we can state that both the list of putative probiotic bacteria and our 
new transformant strain of B. longum are not harmful when exposed to intestinal 
cells and could be selected as probiotics, because can strengthen epithelial barrier 
function  and stimulate nonspecific immunity of intestinal cells on a pig cell model. 
Indeed, we have found out that none of the strains tested that have good adhesion 
abilities presents citotoxicity to the intestinal cells and that non of the strains tested 
can induce cell lines to produce high level of ROS, neither NO2. Moreover we have 
assayed even the capacity of producing certain citokynes that are correlated with 
immune response. The detection of Interleukin-6 was assayed in all our samples, 
including B.longum transformant BKS 7 strain, this result indicates that these 
bacteria can induce a non specific immune response in the intestinal cells. In fact, 
when  we assayed the presence of Interferon-gamma in cells supernatant after 
bacterial exposure, we have no positive signals, that means that there is no 
activation of a specific immune response, thus confirming that these bacteria are 
not recognize as pathogen by the intestinal cells and are certainly not harmful for 
intestinal cells. The most important result is the measure of Trans Epithelial 
Electric Resistance that have shown how the intestinal barrier function get 
strengthen when cells are exposed to bacteria, due to a reduction of the epithelium 
permeability. We have now a new strain of B. longum that will be used for further 
studies above the mechanism of apoptotic induction to “damaged cells” and above  
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the process of “restoring ecology”. This strain will be the basis to originate new 
transformant strains for Serpin encoding gene that must have better performance 
and shall be used one day even in clinical cases as in “gene therapy” for cancer 
treatment  and prevention. 
 
 
 
 
 
 
 
Chapter 13: Credits 
 
PathogenCombat is an integrated project under the EU 6th Framework Programme. 
The project started 1st of April 2005 and will run til April 2010. PathogenCombat 
consistes of 44 partners in Europe and Australia. Of these 24 partners are research 
institutions and organisations, 17 Partners are SMEs and 3 Partners are industrial 
Partners. Food safety is of fundamental importance to the European consumer, the 
food industry and the economy. The impact on trade and competitiveness is very 
substantial. Despite significant investment, the incidence of food derived disease 
still increases in the EU. PathogenCombat attacks this pan-European problem 
through a holistic, multidisciplinary approach towards threats from new/emerging 
pathogens in the entire food chain.  A number of advanced platforms will be 
developed to investigate the survival and virulence expression of pathogens in feed 
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and food, and on contact surfaces in the food chain including the intestinal tract of 
farm animals. The platforms, of which several are used for the first time in food 
safety studies, comprise bioimaging, laser tweezers, phage display/convergent 
evolution, functional mammalian cell models, functional genomics and 
microarrays. New/emerging foodborne bacteria, yeast, filamentous fungi and 
viruses are targeted for milk and dairy products, ruminants, poultry and pigs and 
their meat products. The overall and specific objectives of PathogenCombat can 
briefly be described as follows: production of safe food with none or acceptably 
low levels of pathogens. Determination of factors in the food chain, which enable 
the viability, persistence and virulence of pathogens. Detection and prediction of 
the occurrence and virulence of pathogens in the food chain with molecular biology 
based culture independent techniques and microarrays. Determination of host-
pathogen interaction with functional cell model replacing the use of experimental 
animals. Prevention of pathogen transmission along the food chain by new 
processing technologies and systems, protective cultures and new information on 
host-pathogen interaction. Application in the food chain/SMEs of PathogenCombat 
deliverables. Pathogen control throughout the food chain by new mathematical 
models. Food Safety Management System, which incorporates the deliverables of 
PathogenCombat. Small and medium Enterprises (SME) Network including 
dissemination of knowledge, dissemination of  results and training of SMEs and 
consumer awareness of food safety.  
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